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ABSTRACT
Influenza viruses (IV) have caused untold morbidity and mortality throughout the previous
centuries. These viruses have caused several pandemics that have witnessed the loss of millions of
lives. Today, IVs continue to circulate annually, and the efficacy of influenza virus vaccines are
limited. As IV pandemics in 1918, 1957, and 2009 have shown the world, the push for a universal
influenza vaccine has never been more relevant. While much research has been devoted to
understanding the virology around IVs, the immunopathology of the host-pathogen axis has been
less studied. Recently, there has been much attention on the role of the immune response during
IV infections as they pertain to damage to the host’s lungs. Therefore, pathological immune
mechanisms implicated in lung damage represent targets of therapeutic interventions aimed at
mitigating the lung inflammation and at increasing resistance to influenza-associated bacterial
pneumonia.
In the current study, we identified an interferon (IFN)-γ-regulated subset of monocytes, CCR2+
monocytes, as a critical component facilitating the crosstalk between leukocytes and barrier cells,
and a driver of lung damage in a mouse influenza model. IFN-γ regulated the infiltration and
inflammatory phenotype of CCR2+ monocytes in influenza-infected lungs. At the transcriptional
level, IFN-γ deficiency attenuated the inflammatory phenotype of monocytes. Effector CD8 T cells
were identified as the dominant cell type associated with pathogenic IFN-γ response in our
influenza model. These previously unappreciated immune mechanisms highlight the
immunoregulatory roles of IFN-γ response in regulating the monocyte inflammation and a
molecule of therapeutic target in the future.

viii
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Chapter 1: Introduction

Influenza viruses (IVs) have caused death and destruction of pandemic proportions in
both humans and animals. Seasonally in the United States, IVs infected over 35 million people in
2018-2019 and resulted in over 30 thousand deaths. IVs are spread through aerosol droplets via
coughing or sneezing from an infected person. Contact with contaminated surfaces, like hands,
and then coming into contact with the eyes or mouth is also a mode of transmission. The dry air
of winter makes the spread of IVs much more common. Early in infection, IVs can be shed prior
to the onset of symptoms making the spread of the virus much more likely.
The purpose of this study was to research the immune-related mechanisms that result in
damage to the lungs during the acute phase of viral infection. We developed the hypothesis that
IV results in the migration and accumulation of specific pro-inflammatory immune cells that are
vital to viral clearance but damage the lung epithelium architecture as a consequence of viral
infection. Further, the lung damage mediated but immune cells promote commensal bacterial
adhesion, proliferation, and subsequent infection in the aftermath of IV infection.
This first chapter details the background of the study, specifies the problem, describes the
significance of the problem, and briefly features the methodology used to show the importance
of elucidating a mechanism for immune cell-mediated lung damage.

Background
Influenza viruses are negative sense, single stranded RNA viruses in the family
Orthomyxoviridae (1). Their genome consists of seven or eight segments of RNA that encode for
11 genes and 11 proteins (1). Influenza A viruses (IAV), the family of IVs that have caused the
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largest pandemics from the Orthomyxoviridae family, contain eight segments of RNA (1). IAV
virions are approximately 80 to 120 nanometers in diameter depending on their genetic content
and contain a membrane with embedded glycoproteins (1). Hemagglutinin (HA), a lectin, and
neuraminidase (NM), an enzyme, further extend from the outside of the viral membrane and are
intertwined within the genomic material inside of the membrane (1, 2). Along with the
nucleoprotein intertwined with the genomic material, HA and NM serve to protect the viral RNA
prior to viral entry into a cell (1, 2). These glycoproteins are also responsible for both the entry
and release of the virus into and from the target cell respectively. Hemagglutinin on the surface
of the virion binds to sialic acid residues on the surface of lung epithelial cells facilitating viral
entry via endocytosis (2). Once endocytosed, the cellular compartment fuses with a lysosome
and the pH decreases rapidly thereby releasing the viral genome, the nucleoprotein, and auxiliary
proteins into the cytoplasm of the cell for replication (2).
IAV genomes are negative sense and single-stranded meaning they require an RNAdependent RNA polymerase (RdRp) for replication (1). The viral genome is trafficked into the
nucleus of the cell and subsequently transcribed via the viral RdRp (1-3). The new positive sense
IAV RNA is released into the cytoplasm of the cell where the host’s cellular machinery will
translate the message into viral proteins (1-3).
Once the virus has replicated its genome from the newly synthesized positive sense RNA
into negative sense RNA, the new virion begins the process of assembling at the rough
endoplasmic reticulum and Golgi for export (3). NM on the surface of the new virions cleaves
the cytoplasmic side of the sialic acid residues and triggers the release of the virion (2, 3). From
there, the virus begins the process of infecting more lung epithelial cells.
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The immune response to the viral infection often times indicates the outcome of the
infected individual. Robust production of inflammatory cytokines increases the vascular
permeability of capillaries that lead to the lungs. The subsequent influx of pro-inflammatory
immune cells results in epithelial cell death and further production of cytokines. As a whole,
acute respiratory distress syndrome (ARDS) can set in when the respiratory epithelial barrier that
lines and protects the lungs becomes leaky. An increase in fluid into the lungs makes breathing
difficult for the infected individual as more and more epithelial cells are directly killed by
immune cells or undergo cellular death (apoptosis or necroptosis) from internal signals of
infected cells. The end is result is significant morbidity and mortality caused by influenza virus
infection.

Statement of the problem
In 1918, an H1N1 influenza A virus caused a global pandemic that lasted for 15 months
from the spring of 1918 into the summer of 1919 (4). Over 500 million people, just over onethird of the world’s total population became infected during this time (4). With a death toll
ranging from 17 to 50 million people, this pandemic remains one of the deadliest viral outbreaks
of all time (4). Today, there are seasonal influenza virus vaccines and a few notable anti-viral
therapies that lessen the morbidity of the virus, but the efficacy of each treatment is limited. In
2019, the efficacy of the available seasonal vaccines was estimated by the CDC to be 45% (5). In
2009, another H1N1 influenza A virus caused a pandemic that brought significant morbidity but
limited mortality (5). The CDC estimates that 60 million people became infected in 2009 and up
to 500,000 people died across the globe (5). While limited in disease burden, the 2009 H1N1
pandemic underscores the capability IAVs have to cause pandemics thus, understanding how
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they spread from person to person, replicate inside of their host, and subsequently cause disease
is vital in hindering the next influenza virus pandemic.
Acute respiratory destress syndrome (ARDS) is a result of an over-zealous, damaging
immune response initiated by the host (6). The mortality associated with influenza viruses during
the 1918 pandemic was mostly the result of 20-59-year-old adults becoming sick and their
immune response causing damage to their lungs (6). Since 1918, the field of immunology has
sought to better understand the mechanisms employed by the host’s immune response that both
limit viral replication and limit damage to the host. Specifically, detailing both the innate and the
adaptive immune response as they pertain to cellular damage during IAV infections has been
limited in the field of influenza biology. Further, uprooting the mechanisms by which specific
cells of both branches of the immune response, those being direct cell-to-cell interactions as well
as intracellular signaling, is required to produce better therapies for people infected with IAV.

Purpose of the study
The purpose of this study was to elucidate the cause of pathology as a result of the host’s
immune response during IAV infection. The phenotype of key innate immune cells that have
been associated with lung pathology were assessed during the height of the viral infection in
mice. Thorough immune profiling of mice infected with a pandemic strain of H1N1 influenza
virus resulted in a robust model by which innate immune cell recruitment, activation, and
subsequent immune cell-mediated lung damage could be studied. From these studies, a subset of
innate immune cells, termed inflammatory monocytes (IMs) were thought to cause damage in
virus-infected lungs.
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The specific protein chemoattractants (chemokines) that were required for innate
immune cell recruitment were detailed via specific genetic knock out mice. Using the same
model that was described early in the study, the lack of immune chemokines allowed for the
study of influenza virus in the lungs of mice where damaging cells were absent. The lack of IMs
provided a unique model by which pathology that results from immune cells could be analyzed.
These studies provided insight into the roles of each subset of innate immune cells during viral
infection.
While chemokines are responsible for the recruitment and migration of immune cells,
how these damaging cells become activated is an important mechanism of study. IMs were found
to be recruited into the lungs of IAV-infected mice. An influx of these cells coincided with an
increase in the pro-inflammatory cytokine, IFN-. Without IFN-, the frequency of IMs in the
lungs decreases significantly which correlated with a decrease in lung pathology.
As a whole, the purpose of this study was to analyze immune cell subsets that directly
cause damage to the respiratory epithelium during IAV infection. The mechanism by which these
cells clear influenza virions subsequently damages the host. Going forward, the study presented
here provides a novel mechanism by which the host’s immune response inadvertently causes
significant morbidity during IAV infection and further suggests possible areas of intervention to
decrease the observed seasonal morbidity caused by IAVs.

Research questions
The following research questions were used to guide the research as it progressed: (a)
how do you model influenza virus infections in mice? (b) what is the role of ablating
inflammatory monocyte recruitment to the lungs by global CCR2 knockout? (c) does IFN-
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activate inflammatory monocytes and predispose them to be damaging? (d) what are the
transcriptomic changes that occur during influenza virus infection and does knocking out IFN-
alter the inflammatory state of monocytes? (e) what immune cells are the largest producer of
IFN- during IAV infection? (f) what role does the adaptive immune response have in damaging
the respiratory epithelium during IAV infection?

Conceptual framework
Influenza virus has been a staple in the modern vernacular for centuries. With reservoirs
in both birds and swine, the opportunity for these viruses to continue to infect humans will not
decrease. As H1N1 Influenza A viruses remained a constant threat from their emergence in 1918
until H2N2 viruses caused the next pandemic in 1957. In 2009, the swine flu pandemic brought
the reemergence of H1N1 viruses. While not as deadly as the 1918 pandemic, the total number of
infected people ranged from 500 to 700 million people. A century later, scientists have studied
and mapped virtually every aspect of influenza virus in terms of its replication, transmission,
virulence factors, assembly, and epidemiology. However, the mechanisms by which our immune
systems react to influenza virus in regard to initial viral recognition, clearance of the virus, and
subsequent immune memory has left more questions than answers.
The studies that have provided the framework for studying influenza virus, as well as
studying host-pathogen interactions, will be reviewed in chapter 2. The focus of this study is
aimed around analyzing several of the early immune cell-virus recognition events to determine
what drives lung pathology during acute viral infection. To assess lung pathology during acute
viral infection several working hypotheses were tested under the framework discussed below.
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1. Mice infected with influenza virus A/PR8/H1N1 will experience significant
morbidity via weight loss, posture, and behavior.
2. Cellular influx into the lungs during PR8 infection will be assessed via hematoxylin
and eosin (H&E) staining. Determination of large airway inflammation will also be
determined via H&E staining.
3. The identify, or phenotype, of the cells in the lungs of mice infected with PR8 will be
analyzed via flow cytometry.
4. Changes in the transcriptome of monocytes will be analyzed via RNA sequencing and
the data will be analyzed in an unbiased, blinded manner.
5. Cellular source of pro-inflammatory cytokines that contribute to immunopathology
will be determined via intracellular cytokine staining.

Figure 1. Conceptual Framework
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Design and procedures
This study used C57BL/6 mice as an animal model to study influenza virus infections as
it pertains to viral-host interactions in the lungs. Mice were lightly anesthetized using isoflurane
and 250 plaque-forming units (PFU) of IAV were intranasally administered in 100 µL cold PBS
into each mouse. For several experiments, CCR2-/- and IFN--/- mice were used. Knock-out mice
were bred on a C57BL/6 background and bred in-house or purchased from Jackson Labs. Knockout strains were verified using PCR for presence or absence of the gene of interest. In all
experiments, an equal number of control mice that were lightly anesthetized with isoflurane (in
the same manner as experimental mice) and administered 100 µL cold PBS without IAV.
Control mice were age and sex matched with experimental mice for every experiment. Mice
were monitored daily to assess morbidity via changes in body weight. The percentage of body
weight lost in IAV-infected mice was measured where a 20% decrease from the starting weight
was deemed the cut-off point for euthanasia. After the mentioned days of infection, mice were
euthanized, and their lungs were processed for a variety of experiments.
The large lobe of the lungs was perfused with 1 mL 4% formalin and subsequently
paraffin embedded for histological staining. Hematoxylin and eosin (H&E) staining was
performed to analyze the (a) structure of the airways post-IAV infection (b) cellular influx into
the lungs (c) inflammation around the large airways.
The three smaller lobes were excised using sterile surgical tools. One lobe was fixed in
RNA-Later solution for RNA extraction and analysis. Another lobe of the lungs was
homogenized in a solution containing protease and phosphatase inhibitors for protein
quantification and protein analysis. The remaining lobe of the lungs was used to analyze cellular
populations within the lungs of mice via flow cytometry. A single cell suspension was
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performed, and single cells were immediately surface stained with pre-chosen fluorophoreconjugated antibodies and then analyzed on a flow cytometer.
Flow cytometric analysis was performed using a BD Symphony flow cytometer. All
fluorophore-conjugated antibodies were purchased from BioLegend. Briefly, single cells were
washed and then stained with the optimal, pre-determined concentration of antibodies in 50 µl of
wash buffer (2% FBS in cold PBS). Cells were stained for 40 minutes in the dark at room
temperature before being washed twice with wash buffer. For intracellular staining, cells were
permeabilized after surface staining using the BD fixation/permeabilization kit (BD) and then an
optimal concentration of anti- IFN- antibody was added in 50 µL permeabilization buffer. The
cells were then washed with permeabilization buffer and then normal wash buffer. Cells were
immediately analyzed on a flow cytometer using pre-set conditions. The flow cytometer was
compensated for each color in order to minimize spectral overlap between colors. The data
acquired from the flow cytometer was analyzed using FlowJo (TreeStar) software.
Bronchoalveolar lavage (BAL) fluid was also collected from mice after euthanasia. Cells
and cellular debris were removed from the BAL fluid and cytokine and chemokines were
measured via LEGENDPlex bead array (BioLegend). Bead arrays are a novel technique that
allows for the measurement of proteins concentration in 12 analytes in a single experiment.
This study also utilized RNA sequencing from sorted monocytes to determine total
transcriptomic changes in inflammatory profiles. Seven days post-IAV infection, uninfected
C57BL/6 mice (mock) C57BL/6 mice infected with IAV (WT-PR8), and IFN--/- mice infected
with IAV (IFN--/--PR8) were euthanized and whole lungs were aseptically collected. After
preforming a single cell suspension, single cells were sorted via magnetic separation and column
filtration (Miltenyi). RNA from the sorted monocytes was extracted using a Qiagen RNA
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extraction kit (Qiagen) and subsequently PolyA RNA-Seq libraries were prepared using a
NEBNext Ultra II RNA-Seq library kit. Once the adapters from each read were trimmed, the
reads were aligned to a mouse genome (mm10) with HISAT2. Differentially expressed genes
(DEGs) between groups were identified using the R/Bioconductor package DESeq2 v.1.24.0.
The cutoff for DEGs was determine using an adjusted p value of less than 0.05. Heatmaps were
created using Log2-fold change of individual genes from each group of monocytes. Pathway
enrichment analysis was performed using Ingenuity Pathway Analysis (IPA). Canonical
pathways were identified with a log10 significance (p-value) cutoff of 1.3.
Data are presented as the mean ± SEM. Multigroup analyses were performed using oneway ANOVA, followed by Tukey’s post hoc analysis. Comparisons between two groups were
performed using the Mann-Whitney nonparametric test. Statistical analyses were performed with
Prism 7.04 (GraphPad Software, La Jolla, CA, USA).

Significance of the study
This study is significant because it shows how IFN- drives lung damage mediated by
CCR2+ monocytes during influenza virus infections. The field of influenza virology has long
tried to decipher the mechanisms by which the host’s immune response damages the lungs in
order to clear the viral infection. The development of an influenza virus mouse model, coupled
with knock-out mouse models to study the role of CCR2 and IFN- during IAV infection, have
provided insight into IAV pathogenesis and lung pathology mediated by the host’s immune
response. Information can be drawn from this study to impact the outcome of people with severe
immunological reactions to IAV. Further, these findings lay the groundwork for understanding
the pro-inflammatory versus anti-inflammatory paradigm of inflammatory monocytes, and
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potentially lung-resident macrophages, as they pertain to IAV infections. Going forward, this
study will held elucidate mechanisms employed by the immune response that clear viral
infections in the lungs but also cause severe cellular damage as well.

Limitations of the study
This study tested the hypothesis that IFN- drives lung damage through the activation of
CCR2+ monocytes during influenza virus infection. As with any study, there are inherent
limitations that must be considered.
The researcher has noted the following limitations: (a) the long-term consequences of
removing IFN- from IAV-infected mice, and thus, a large component of viral clearance, must be
considered and the ramifications of potentially chronic rather than acute viral infections noted (b)
transcriptome changes via RNA-sequencing analysis from sorted monocytes must also be tested
on the protein level rather than the just the RNA level in order to test for the observed differences
(c) in vitro studies of direct cell-cell interactions where IMs induce apoptosis via TRAIL or FasL
should be performed to analyze the extent to which these leukocytes have in a controlled setting
(d) subsets of helper T cells should be analyzed to address their role in the activation of the
humoral immune response, the anti-inflammatory cellular response, and the production of
various cytokines that further interact with all branches of the immune response (e) without IFN, the class-switching capabilities of B cells to produce IgG against IAV should be analyzed as
means of preventing future IAV infections.
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Delimitations of the study
The researcher imposed the following delimitations to this study: working with model
organisms can be difficult to control for as each living organism is inherently different thus
producing implicit bias into each study. The researcher treated each mouse as if they were the
exact same but limitations on differences in immune function between mice cannot be altogether
dismissed. Further, interpretation of the data may also produce limitations.
The researcher made the following assumptions throughout the study: (a) collecting
100,000 events for flow cytometry is unbiased and provides an accurate representation of the
total number and frequency of cells in the lungs. (b) the collection of 10,000 events for cytokine
bead array analyses provides an accurate representation of the analytes measured in the
experiment via flow cytometry. (c) both control and experimental mice were treated in a similar
manner such that isoflurane and carbon dioxide were held constant when anesthetizing and
euthanizing mice respectively. Isoflurane and carbon dioxide did not skew the data or alter the
findings in any meaningful way. (d) only mice bred on a C57BL/6 background were used and
knock-out mice bred on this background were the same as wild-type mice with the exception
being the gene/protein that was knocked out. (e) measuring weight loss in mice throughout
infection is a measure of morbidity and severity of disease. (f) the processing of tissues for
protein analysis, RNA extraction and measurement, fixation and histological analysis, and single
cell suspensions were the same through each experiment and any observed differences are due to
the independent variable rather than experimental factors. (g) 100 µL of PBS containing 250
PFUs of PR8 for experimental mice or simply PBS were administered to each mouse and as
such, the virus reached beyond the nasopharynx into the deeper alveoli of the lungs.
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Definition of terms
Throughout the course of experimentation, the researcher has chosen terms and phrases
that are common and are clarified below. The origin of each term is cited following the definition
of the term:
Acute Respiratory Distress Syndrome. Type of respiratory failure characterized by the
onset of inflammation into the lungs causing an increase in fluid and organ failure due to the lack
of oxygen (Fan, 2018).
Alveolar Epithelium. The alveolar epithelium is comprised of alveolar type (AT) I and
ATII cells where ATII cells primarily produce pulmonary surfactants essential for efficient gas
exchange and for maintaining alveoli’s structural integrity and contribute to lung defense by
secreting antimicrobial factors, cytokines, and chemokines (Herzog 2008, Crouch 2001).
Apoptosis. Programmed, controlled cellular death (White 2011).
C-type lectin receptor. CLR, family of transmembrane and soluble receptors that
contain carbohydrate recognition domains to recognize a wide variety of glycans (Lavelle 2010).
Chemokine. A class of cytokine that serves as an attractant for white blood cells
(Stegelmeier 2019).
Co-infection. Simultaneous infection of a host with multiple pathogen species (Keller
2016).
Cytokine. Proteins, such as interleukins, interferons, and growth factors, that are secreted
by cells of the immune system to affect the function of either themselves or other cells
(Stegelmeier 2019).
Flow Cytometry. Experimental technique used to measure and detect the physical and
chemical properties of a population of cells or particles (Herzenberg 2006).
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Hemagglutinin. Hemagglutinin is the major glycoprotein responsible for viral entry into
cells of the upper respiratory tract by attaching to sialic acid residues (Wilson 1981, Boonsta
2018).
Leukocytes. White blood cell derived from hematopoietic stem cells in the bone marrow;
primarily innate immune cells: monocytes, macrophages, eosinophils, neutrophils, mast cells,
and basophils (Lamichhane 2019).
Necroptosis. Cell-programmed necrosis is the phenomenon by which cells
uncontrollably die and release their intracellular content into the periphery (Majno 1960, Dhuria
2018).
Neuraminidase. Also called Sialidase, an enzyme on the surface of Influenza Viruses
that cleave glycosidic linkages of neuraminic acids (McCullers 2003).
Nucleotide binding and oligomerization-domain like receptor. Intracellular pattern
recognition receptor that recognizes conserved molecules via phagocytosis or endocytosis;
expressed on immune cells and epithelial cells in the lungs (Crystal 2008, Lavelle 2010).
Pandemic. An outbreak of a disease that is not limited to one area but rather, has spread
globally (Pleschka 2013).
Pattern Recognition Receptor. PRR, germline encoded sensors of the innate immune
response that recognize conserved molecules typical of pathogens or damaged tissue (Choi
2019).
Respiratory epithelium. Ciliated columnar epithelium that lines the respiratory tract and
mucosal membranes in the lungs to moisten and protect the airways (Hansen 1975).
Retinoic acid inducible gene-1-like receptor. RLR, recognition of conserved viral
molecules in the cytoplasm of immune cells (Lavelle 2010).
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RNA-dependent RNA-polymerase. Enzyme responsible for the replication of RNA
from an RNA template, typically coded for in the genome of a virus or encapsulated within the
viral capsid/envelope (Hay 2001, Pleschka 2013).
Toll-like receptor. TLR, expressed both intracellularly and extracellularly by cells of the
innate immune response and recognize structurally conserved molecules typical of pathogens or
host proteins (Lavelle 2010).

Summary
Chapter 1 presented background for the study, specified the unique problem with hostpathogen interactions, the significance of that problem, and concluded with a brief overview of
the context and methodology used for the study. The first chapter described the limitations of the
study and why these limitations are important. In chapter 2, a review of the relevant and current
literature will be presented. The definitions of key words and phrases were included in chapter 1
for brevity and clarity prior to the review of the literature. The virology of influenza virus, the
physiology of the respiratory epithelium, and the immunological aspect of the host-pathogen
interactions is summarized in chapter 2. The related impact of different immune cells on targeted
epithelial cell death as well as effector cytokines that prolong the pro-inflammatory immune
response will also be analyzed in the next chapter. Chapter 3 presents the method design of the
study including the animal model that was used and the relevant. The methodology behind each
experiment as well as how the data were collected is also discussed. The results derived from the
experimental design described in chapter 3 will be presented in chapter 4. Each experiment as
well as statistical analyses used to determine the significance of the data is explained as well.
Chapter 5 will conclude with the limitations and further research that can be done after detailed
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analysis of the data. The research described throughout aims to provide a mechanism by which
interferon- activates inflammatory monocytes in the lungs during acute influenza A virus
infection thereby creating a hyper-inflammatory response in the lungs that damages the
respiratory epithelium of the host in addition to clearing the virus.
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Chapter 2: Literature Review

Purpose of the review
In reviewing the extant literature regarding the mechanisms by which influenza virus
promotes lung damage during acute infection, numerous labs have published a variety of studies
that detail different aspects of this medically-relevant problem. However, correlating the specific
role monocytes and early innate immune cells with influenza virus infection is poorly understood
and thus, this review serves as the framework by which the hypotheses tested were conceived.
The purpose of this review is to identify background information regarding the virology
and immunology of influenza viruses so as they are better understood from a functional aspect as
well as fully understand how influenza viruses a) are transmitted b) how they enter a cell c) how
they replicate inside of cells and, d) how influenza virions escape from their host cells to infect
other cells. Next, this review serves as a basis for non-human influenza virus infection models.
Influenza viruses infect a broad range of creatures but determining the most cost-effective,
ethical, and useful animal model is of great importance when conducting virus research. This
review details how the field of influenza virus research as well as research into the immune
system has used specific mouse models to study influenza viruses. The last goal of this literature
review is to underline the significance of the studies performed here and specify the gaps in our
current understanding of influenza virus-mediated lung damage.
The intent of this review is to provide members of the public, educational leaders, and
research scientists alike on the medical relevance of lung damage during influenza virus
infection that is a result of the host’s immune response as well as highlight where the field of
virus-based immunology is heading.
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This review will cover a variety of topics and will be guided by the questions: (a) how
does influenza virus infect its host and spread from person to person?( b) What are the
mechanisms of lung damage that are mediated by the virus, monocytes and macrophages, other
innate cells that are recruited early in infection, and the role of the adaptive immune response in
damaging the lungs? (c) How do interactions between epithelial cells in the lungs and early
immune cells mediate inflammation? (d) What are currently used and potential therapeutic
interventions that may disrupt the crosstalk between epithelial and immune cells during acute
influenza virus infection?
The body of literature regarding influenza viruses and the innate immune response
separately is quite large and thus, they are separately beyond the scope of this review. Further,
there are many other respiratory viruses besides influenza virus that cause acute respiratory
infection and damage. The focus of this review is solely based on influenza viruses. Further, the
damage mediated by influenza virus infection can often times be the result of other non-viral
factors such as immunodeficiencies or recurrent lung damage, like allergies or asthma. This
review focuses only on acute influenza virus infections and the damage caused by the innate
immune response. Through a thorough review of the literature, the framework by which
influenza virus mediates damage in the host’s lungs and the role of the host’s immune response
in further damaging the lungs will be displayed and result in a greater understanding of such a
medically and economically relevant problem.

Literature search procedures
The literature reviewed for this chapter were accessed through several online databases
including PubMed and Google Scholar. Print editions of several articles were also used when the
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specific article could not be accessed online. Every article used for this review is experimental
and data driven. Qualitative research was not included. Non-peer-reviewed or pre-published
articles were not used in this review as every article that was used for this review was accessed
from a published, peer-reviewed scientific journal.

Methodological issues in the research
During the review of the literature, a recurrent problem emerged where correlative
evidence of epithelial cell damage in the lungs mediated by early, innate immune cells was
scarce. Further, detailed analyses of monocytes and the mechanisms by which they are recruited
to the lungs during influenza virus infection was limited in both characterization of these cells in
the lungs and recruitment of monocytes into the lungs. Therefore, multiple sources for each topic
were used to piece together the gaps in the literature. The synthesis of virology, immunology,
and in some instances, pulmonology represented in this review were needed to better understand
how the host’s response to acute viral infection mediates the majority of the damage observed in
the lungs.
Another problem that presented itself was the lack of epithelial cell studies in response to
ligands on functional monocytes, influenza virus envelope proteins, and a variety of proinflammatory cytokines. This review details a variety of articles that use these effector molecules
separately as a means to synthesize the mechanisms of lung damage.

Inclusion and exclusion criteria for literature review
As noted earlier, quantitative, published, peer-reviewed articles from distinguished
journals were used in this literature review. The recency of the articles was limited to the past 20
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years. When addressing influenza viruses, studies that used animal models, typically mice, or
human clinical trials were used. Other animal models, such as ferrets or apes, were excluded on
the basis of cost, ethics, and availability of the animals. Typically, studies that used adult
subjects were used and young or elderly subjects were excluded due to the biological relevance
of pandemic influenzas viruses causing mortality in adults (ages 20-59 typically), the ethics of
working with juvenile mice, and the length of time and ethics of working with aged mice.

Influenza Virus Overview
Influenza viruses belong to the viral family, Orthomyxoviridae, and contain a multisegmented, negative-sense, single stranded RNA genome (1). Influenza is also an enveloped
virus derived from the target cell that includes two major glycoproteins and the M2 ion channel
(1). These two glycoproteins are hemagglutinin (HA) and neuraminidase (NA) (1-3). The
envelope surrounds the viral core which houses the viral genome (1). The proteins inside of the
envelope form intricate interactions with the viral genome to create the viral nucleoprotein (NP)
(1). The nucleoprotein encapsulates the viral genome until the protein components become active
(1). Influenza virus genomes have eight different segments that encode for between 11 and 14
genes depending on the strain of virus (1).
Hemagglutinin is the major glycoprotein responsible for viral entry into cells of the upper
respiratory tract via the attachment of sialic acid residues. There are 18 different subtypes of
hemagglutinin but HA1, HA2, and HA3 are found in human influenza viruses (1-3).
Hemagglutinin is an integral membrane trimer consisting of three monomeric subunits (3). Each
monomer consists of HA1 and HA2 regions that are connected by two disulfide bridges (3).
Taking a cylindrical shape, the function of HA is pH-dependent where at neutral pH, the peptides
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at the N-terminus responsible for membrane fusion between the virus and the host cell is
concealed in a hydrophobic pocket (1-3). Upon recognition of monosaccharide sialic acid
residues of target upper respiratory cells, the HA1 portions of HA will bind and attach the viral
envelope to the outside of the target cell (3). Once attached, the cell will engulf the viral particle
via receptor-mediated endocytosis and form an endosome inside of the cell (3). Once
endocytosed, the endosome will begin to acidify after fusing with a lysosome (3). As the
lysosome containing the virus acidifies (and the pH decreases), the fusion peptide component of
the HA1 subunit will dissociate with the H2A domain which allows for a conformational change
to the H2A subunit (3). Through this conformational change, the H2A subunit brings the inner
membrane of the lysosome into close contact with the virus’s envelope which allows for the
fusion of the two membranes (3). Simultaneously, the acidification inside of the lysosome allows
for the viral RNA and viral ribonuclear proteins to detach from the matrix protein 1 (M1) inside
of the nucleoprotein (3). Once the viral envelope fuses with the cell membrane, the viral proteins
inside of the envelope are released into the cytoplasm of the infected cell (1-3).
Influenza virus is unique in the fact that its eight viral RNA segments must traverse the
contents of the cellular cytoplasm and find their way into the nucleus of the cell to replicate (1,
4). Viral RNA wraps around viral proteins where they form ribonucleoprotein (RNP) complexes
(1, 4). Once the RNP complexes have been released into the cytoplasm they must be trafficked
into the nucleus. Influenza proteins PB2 and NP have nuclear localization signals that interact
with host karyopherins, a broad family of cargo molecules that import and export molecules into
and out of the nucleus respectively (4, 5). Specifically, karyopherins  and , and the small
GTPase, Ran, collectively identify the nuclear localization signal on PB2, M1, and NP proteins
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then in a GTP-hydrolysis-dependent manner, Ran translocates the viral RNP complexes into the
nucleus for replication (4, 5).
Once inside of the nucleus, the viral RNA must be replicated and thus, influenza brings
along its own RNA-dependent RNA polymerase (RdRp) in the form of the RNP complex (5, 6).
Once inside of the nucleus, the RNP complex dissociates from the viral RNA and forms the
RdRp (5, 6). The 5’ and 3’ ends of influenza RNA are conserved and are complementary thus,
they transiently bind forming double stranded viral RNA for a brief period of time (5, 6). This
allows for the RdRp to bind and begin synthesizing a complementary strand of influenza RNA
that can be used as a template for negative-sense influenza RNA. For transcription and
subsequent influenza protein synthesis, the host’s RNA polymerase II is co-opted (5, 6).
Once the viral RNA has been replicated and transcribed, viral M1 assists with the
translocation of viral RNA into the cytoplasm (1, 5, 6). The nucleoprotein once again forms and
encapsulates the virus’ genomic RNA as well as the viral proteins (1, 5, 6). At the late stages of
viral assembly, HA, NA, and M2 integrate into the plasma membrane while M1 once again
forms associations with the envelope and the RNP complexes inside of the nucleoprotein (1, 5,
6).
Neuraminidase has 11 different subtypes thus; the serotype of influenza virus is termed
based on the combination of hemagglutinin and neuraminidase glycoproteins present on the
envelope surface (1, 7). The infection of airway epithelial cells in the upper respiratory tract is
dependent on NA activity (7). NA possesses receptor destroying activity and virion escape from
a cell is dependent upon NA activity (7). In order for virion release to occur, NA cleaves sialic
acid moieties from cellular receptors thus allowing for viral budding and release. As both HA
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and NA are able to cleave sialic acid residues, HA receptor attachment and NA receptor
destroying activity must be balanced (1, 7).
The replication cycle of a virus requires many concerted steps in order to ensure the virus
replicates its genome effectively and efficiently while subsequently hijacking cellular machinery
to produce new viral proteins. Through many of these steps, the cell is able to recognize the virus
or viral components and respond in kind. Recognition of double stranded RNA (dsRNA) in the
nucleus by RNA-activated protein kinase (PKR) begins a cascade where RNase L cleaves the
dsRNA as well as induces apoptotic cell death (8). Production of interferons by recognition of
viral RNA in the cytoplasm also leads to a pro-inflammatory, pro-apoptotic state (8). Influenza
virus has many different strategies to overcome host defenses against viruses. The NS1 protein
of influenza virus binds to its own dsRNA effectively hiding it from the host PKR and RNase L
response. In turn, this also blocks one of the major cascades for interferon production (8). NS1
can also bind to RIG-1 thereby inhibiting its binding to single stranded RNA and preventing
degradation of the viral genome (8).
Once all of the components of influenza virus, those being the eight negative-sense RNA
segments, HA, NA, M2, M1, and the RNPs, the virion forms together and buds from the cell.
The mature and fully processed forms of HA, NA, and M2 become integrated into the host cell’s
plasma membrane (1, 9). M1 then assembles at the membrane and assists in the recruitment of
the RNPs (9). During this process, HA activates the ERK cascade which further allows for the
production of viral proteins (10). At the plasma membrane, the viral components become
enveloped resulting in the formation of a new virion at the apical surface of the cell (1, 9). Here,
NA cleaves sialic acid residues on the cell surface allowing for both efficient budding and
release of the virion as well as preventing HA from re-binding to surface sialic acid moieties on
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the surface of the previously-infected cell (1, 9). The newly released virus is then free to begin
the infection process again when it comes into contact with sialic acid residues on neighboring
cells.
Currently, there are seasonal tetravalent influenza vaccines that allow for moderate
protection against a range of influenza A and influenza B viruses (11). However, in the most
recent influenza season, the CDC estimated the efficacy of the vaccine to be 47% (11). Several
antiviral treatments exist with their efficacy ranging from 60-90% (12). This estimate is based on
providing antiviral treatment within the first 48 hours of onset of the disease (12). As mentioned
previously, a person infected with influenza virus is asymptomatic and can spread the virus in the
form of aerosol droplets for days prior to the onset of symptoms making antiviral therapy
difficult to administer early on (12). Antivirals are an effective treatment but are not equipped to
prevent others from becoming infected as individuals infected with influenza virus often
experience an incubation period prior to the onset of symptoms where they shed infectious virus
particles.
Influenza virus infection causes morbidity in several different ways. In humans, influenza
virus infections are typically limited to the respiratory tract where epithelial cells are infected and
subsequently lysed resulting in mucous production and induction of the innate immune response
(13). At the site of epithelial damage, innate immune cells, such as neutrophils, monocytes, and
macrophages, will secrete potent inflammatory cytokines that contribute to inflammation (13).
Together, these events result in fever, cough, and mucous production. If the viral infection
spreads from the respiratory epithelial cells of the upper respiratory tract to the alveoli deeper in
the lungs, viral pneumonia may occur (13). The morbidity and mortality associated with
pandemic strains of influenza virus most commonly follow this route of infection where viral
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pneumonia occurs (12, 13). The host’s immune response also contributes to morbidity via the
over-zealous production of inflammatory cytokines that damage the respiratory tract and the
alveoli. Epithelial cell death, over-production of inflammatory cytokines, and an influx of fluids
into the alveoli may result in acute respiratory distress syndrome and subsequent death.
Acute respiratory distress syndrome (ARDS) is characterized by rapid infiltration of
immune cells into the lungs where they secrete large amount of pro-inflammatory cytokines (14).
As a result of IAV infection and subsequent immune activation, the respiratory system begins to
fail. Specifically, gas exchange in the lungs becomes dysregulated as fluid rapidly impairs the
function of the microscopic air sacs responsible for exchanging carbon dioxide for oxygen (14).
Atelectasis, or collapsing of the lungs, and hypoxemia are often the result of ARDS and may
require ventilation of the patient (14). Patients infected with IAV that progress to ARDS as a result
of an increase in fluid caused by cytokine release typically have a poor prognosis (14, 15). The
mortality rate associated with ARDS that progresses to hypoxemia and lung collapse is between 9
and 20%. Bacterial sepsis or multiorgan failure resulting from ARDS increases the mortality rate
up to 30% (14, 15). ARDS is also an incredibly debilitating disease where lung function can be
severely impaired as both the epithelial and endothelial layers of the respiratory epithelium, along
with the air sacs responsible for gas exchange, become damaged and the quality of life for people
afflicted by ARDS decreases drastically. The sum of the events surrounding viral infection and the
response initiated by the host result in morbidity. While both viral and host factors contribute to
morbidity in the human population, commensal bacteria also play a large role.
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Secondary Bacterial Infections
Streptococcus pneumoniae (Spn), Klebsiella pneumoniae, and Staphylococcus aureus
(SA) are commensal bacteria generally found on the skin and in the nasopharynx of humans (16).
However, during the 1918 and 1957 influenza virus pandemics, the greatest mortality was
associated with bacterial pneumonia caused by these commensal bacteria (1, 16). The host’s
immune response is adept at coexisting with these bacteria and very rarely are they able to
colonize in large quantities and damage the host without some prior trigger. Influenza virus is
one of those triggers. While Spn and SA are the most common bacteria that cause infections after
IAV infection, other bacteria may also colonize the upper respiratory tract and cause significant
morbidity. (16) For example, Legionella pneumophila, Streptococcus pyogenes, Nesseria
meingitidis, Moraxella catarrhalis, Haemophilus influenzae, Pseudomonas aeruginosa, and
other Staphylococcus and Streptococcus species have been observed to cause secondary
infections (17).
Focusing on Streptococcus pneumoniae (Spn) because it caused the greatest amount of
mortality in 1918 and 1957 pandemics, influenza virus infection causes damage to the
nasopharynx and respiratory tract of the human lungs thereby allowing for Spn to adhere,
colonize, and become infections to the host (17). Damage on the surfaces of airways mediated by
IAV exposes potential attachment sites for bacteria via the deposition of fibrin and the inherent
repair mechanisms that regenerate epithelial cells (17). The IAV-induced necrosis of epithelial
cells impairs the mucociliary clearance mechanisms by which debris from deep in the small
alveoli of the lungs is removed (17). Bacteria present in the oronasopharynx then have access to
the lungs to colonize. The neuraminidase activity that cleaves sialic acid residues when
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influenza virions are released from the cell also results in the exposure of cellular receptors that
make the lung environment favorable for Spn adherence (9, 17).
Spn releases hydrogen peroxide (H2O2) which directly interferes with inflammasome
formation thereby blocking important early-innate immune cytokines like IL-1 and IL-18 (18).
Immune cells that experience prolonged or transient interactions with IAV antigens may induce
cellular anergy and allow for a more permissible environment for bacterial adherence and
colonization as the immune response becomes less active (18). Sustained desensitization to TLR
ligands, specifically TLR2 on the outer membrane of immune cells, leads to a decrease in
neutrophil recruitment following the clearance of IAV (18). While the decrease in TLR2 activation
results in less immunopathology, the lack of neutrophil recruitment results in a more permissive
environment for Spn and SA colonization (17, 18).
The synergy between influenza virus infections and bacterial adhesion is also
recapitulated in mice where the IAV virulence factor, PB1-F2, is administered. PB1-F2
administration led to an increase in potent pro-inflammatory cytokines, IFN-/, IFN-, TNF-,
and IL-6. IL-10 was also increased after PB1-F2 administration which further decreases the
recruitment of pro-inflammatory immune cells thereby making the site of IAV infection more
permissible to bacterial adherence (1, 19). PB1-F2 decreases the phagocytic ability of neutrophils
and macrophages as well which hinder the ability of the immune response to inhibit bacterial
colonization (19). Further, as immune cells from all over the host’s body begin to migrate to the
site of infection, vascular permeability is increased (19). Lung damage makes the vascular
endothelium leaky and Spn is able to spread and become septic.
Spn is the most common cause of community acquired sepsis worldwide (17). Spn is a
Gram positive, facultative anaerobic bacterium that has the potential to infect the air sacs of the
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lungs (17, 20). Risk factors for community acquired pneumonia via Spn infection include
underlying pulmonary diseases, immunodeficiencies or immunosuppressive conditions, smoking
habits, IAV infections, and age. Individuals who are over the age of 65 are four-times more
likely to experience community acquired pneumonia compared to younger people (20). While
pneumococcal vaccines exist, their efficacy in people over 65 years of age is variable as the
immune systems of elderly patients are often what make them more susceptible to community
acquired pneumonia to begin with (20). This phenomenon, termed secondary bacterial infection,
can lead to toxic shock syndrome as even more cytokines are produced to inhibit bacterial
superinfection and the host may die (20). In the worst influenza virus pandemics humans have
accounted for, these secondary bacterial infections have led to the greatest amount of mortality.
With several hundred strains of Spn, current vaccines do not cover all strains of bacteria and
antibiotics may not be effective either as the spread and propagation of the bacteria increases due
to the damaged host (20).

Mechanisms of lung damage
Influenza-mediated cell death
Influenza virus (IV) is able to directly damage and kill epithelial cells through a variety
of viral escape strategies. Further damage to epithelial cells is caused by intracellular recognition
molecules inherent to the immune response when components of the virion are recognized.
Apoptosis of infected or damaged epithelial cells represent the main form of damage to the
epithelium (airway epithelial cells, goblet epithelial cells, and airway basal cells) during the early
stages of IV infection (21). Once the infected cell recognizes a portion of IV intracellularly, the
cell begins to condense, compacting everything inside of the cell’s cytoplasm (21). This limits
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the ability of the virus to replicate. This also allows for the induction of initiator apoptotic
proteins (caspases) to come into contact with viral proteins thereby beginning the apoptotic
cascade (21). These initiator caspases dimerize which then allows for autolytic cleavage of
effector caspases (21). Effector caspases then activate DNA proteolytic enzymes which begin to
fragment cellular DNA (21). This fragmentation of cellular DNA stresses the cell and inhibits the
further production of regulatory proteins. This stress response results in cellular blebbing and
apoptosis of the cell. Here, epithelial cells attempt to limit the production and spread of IV
through cell death (21). However, apoptosis also limits the activation of the innate immune
response as apoptosis does not induce a large inflammatory response. Through necroptosis, the
immune response becomes activated.
Necroptosis, or cell-programmed necrosis, is the phenomenon by which cells
uncontrollably die and release their intracellular content into the periphery (22). The DNAdependent activator of IFN regulatory factors (DAI) is required for receptor-interacting protein
kinase 3 (RIPK3) induction which leads to type I IFN production (23). During IAV infection,
IAV RNA is recognized through DAI and leads to either apoptotic or necroptotic cell death (1,
21, 23). IAV RNA recognition by DAI activates RIPK3 and subsequently recruits mixed lineage
kinase domain like pseudokinase (MLKL) via phosphorylation to create the necrosome (23).
Conversely, receptor-interacting protein kinase 1 (RIPK1) in the presence of caspase 8 and Fasassociated protein with death domain (FADD) leads to apoptosis rather than necroptosis (23).
Influenza virus is able to mediate necrosome formation and necroptosis as the primary means of
cell death during infection by limiting the presence of caspase 8 (21, 23). The matrix 1 (M1)
protein of IAV specifically binds to caspase 8 thereby skewing the cell to undergo inflammatory
necroptosis rather than apoptosis (21, 23). The content released from cellular necrosis consists of
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DNA, DNA-associated proteins, and cellular organelles all of which elicit a robust immune
response (23). The innate immune response recognizes conserved moieties of damaged cells
(termed damage-associated molecular patters, or DAMPs) which in turn activates them (22, 23).
Through this activation, innate immune cells begin to express pro-apoptotic ligands on their cell
surface to induce apoptosis in IV-infected cells (23). These ligands and their role in the induction
of cell death will be discussed in the next section.
Unlike other respiratory viruses like rhinoviruses and adenoviruses, influenza virus is
able to directly damage epithelial cells. Viral escape is often times mediated by the apoptotic
death of cells thereby offering a mechanism of viral escape via the blebbing of the cell
membrane (21). Necroptosis and the subsequent recognition of cellular debris by the innate
immune response increases vascular permeability in the blood vessels lining the lungs which
allows for the enhanced spread of IV virions (23). While damaging, the death of cells in the
respiratory epithelium caused by IV is incredibly small when compared to the role of the
immune response in tissue damage during viral infection.

Innate immune response
Once influenza virus has begun to infect the host, the host’s innate immune response
elicits a robust, nonspecific response to the infection. When recognizing the structure of the
influenza virion, it is clear that there are many unique, conserved structures that the innate
immune response can recognize (24). Through these conserved structures, innate immune cells
use toll-like receptors (TLRs), C-type lectin receptors (CLRs), nod-like receptors (NLRs), and
Rig-I-like receptors (RLRs). (24) Much like the recognition of DAMPs, this nonspecific
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recognition of conserved pathogen -associated molecular patterns (PAMPs) is what makes the
innate immune response non-specific, effective, and sometimes dangerous (24).
During the early stages of an IV infection, RLRs or NLRs inside of infected epithelial
cells recognize viral RNA (24). As noted earlier, the recognition of IV RNA activates initiator
apoptotic caspase (21). However, the threshold of initiator caspases required to cleave and
activate effector caspases that commit an epithelial cell to undergo apoptosis can be large. Once
the innate immune response has been activated by DAMPs or components of IV (proteins,
glycoproteins, and/or RNA), immune cells begin to upregulate pro-death ligands that further
commit a cell to undergo apoptosis when they come into contact with their respective pro-death
receptors on a cell’s surface. The recognition of IV by an epithelial cell results in greater
production and upregulation of these pro-death receptors (25). Some innate immune cells do not
upregulate pro-death ligands on their cell surface but rather, phagocytose infected and dying cells
or aid in the slowing of viral spread (25). Even further, some innate immune cells bridge the gap
between the innate and the adaptive immune response as a means to develop cellular memory
against IV or provide the last push to finally clear the viral infection (25).

Cells of the Innate immune response
Monocytes and macrophages are pro-phagocytic leukocytes that also upregulate proinflammatory cytokines like tumor necrosis factor (TNF), IL-1 and IL-12 (26). Monocytes are
produced in the bone marrow from their precursor, monoblasts, and then leave to circulate in the
blood for several days (26). Under homeostatic conditions, half of circulating monocytes will
stop circulating and differentiate into tissue-resident macrophages or myeloid-lineage dendritic
cells (26). The other half of monocytes will migrate and be retained in the spleen. During an IV
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infection, production of chemokines, CCL2 and CCL7 further recruit monocytes via interaction
with the pro-inflammatory receptor, CCR2 (26, 27). CCL2 interactions with CCR2 facilitate
calcium mobilization and inhibition of adenylyl cyclase thereby attracting monocytes from the
bone-marrow (27). These inflammatory monocytes (IMs) migrate through the blood stream
following the CCL2 chemokine gradient until they reach the site of infection (26, 27). During IV
infection, the site of infection is the lungs. Monocytes and macrophage have three main antimicrobial properties: phagocytosis, cytokine production, and antigen presentation (26, 27).
Monocytes and macrophages recognize conserved PAMPs and DAMPs via their pattern
recognition receptors (PRRs) and initiate uptake and subsequent phagocytosis of the target (26).
Through the opsonization of pathogens or foreign molecules via complement or antibodies, these
myeloid cells can also recognize and phagocytose the opsonized particles (26, 27). As it relates
to IV, monocytes and macrophages are also able to directly kill virally-infected cells through
direct killing (26, 27). The presentation of pro-apoptotic receptors (termed death receptors) on an
IV-infected cell can interact with pro-death ligands on the surface of monocytes and
macrophages (26, 27). The major ligands on the surface of monocytes and macrophages that
induce death are Fas ligand (FasL) and TNF receptor apoptosis -inducing ligand (TRAIL) (27). It
is here that much of the cellular damage to the host occurs.
Recruitment of IMs via CCL2 secretion results in a massive influx of pro-inflammatory
cells that will secrete more pro-inflammatory cytokines thereby modulating the immune response
to recruit more inflammatory cells and directly kill infected cells (26, 27). FasL and TRAIL
induce apoptosis and necroptosis in epithelial cells (27). Mentioned earlier, the M2 protein of IV
also directly damages and kills epithelial cells. The result of IMs killing epithelial cells coupled
with viral-mediated cell death leads to massive cell damage and death, fluid build-up, and
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potential complications (27). Further, the production of pro-inflammatory cytokines by IMs
results in a negative feedback loop where more inflammatory monocytes and inflammatory cells
are recruited (26, 27). The cellular damage perpetrated by IMs through direct cellular killing and
further recruitment of inflammatory cells, being IMs or otherwise, leads to gross cell death and is
a significant cause of morbidity seen during IV infection (26, 27).
Neutrophils are professional phagocytic cells and are the most abundant circulating
leukocyte in the blood (28). They develop in the bone marrow from myeloblasts and are the first
responding cells to most infections (28). Usually thought of as anti-bacterial cells, neutrophils
play a large role in acute respiratory distress syndrome (ARDS) which can be a consequence of
respiratory IV infection (28). Recognition of double stranded RNA via TLR7 on neutrophils
results in the production of TNF and CCL3 which further recruit neutrophils to the IV-infected
lungs (28, 29). Neutrophils serve several functions during viral infection via phagocytosis, the
production of reactive oxygen species, and NETosis (28).
Neutrophils are able to phagocytose cellular debris during IV infection (28). Cells that
have undergone apoptosis or necroptosis will be recognized by PRRs on the surface of
neutrophils, internalized, and subsequently removed (28).
Neutrophils contain primary granules that directly damage or degrade components of
bacteria (azurophilic granules) and secondary granules which form reactive oxygen species and
lysozymes (28, 29). During IV infection, secondary granules and myeloperoxidase (MPO) are
used to produce reactive oxygen species (ROS) via the induction of NADPH oxidase (30).
Reactive oxygen species are produced when molecular oxygen is reduced which results in the
production of superoxide (30). Dismutation of superoxide forms hydrogen peroxide which, when
partially reduced by MPO, produces a hydroxyl radical (ROS). (30) Hydroxyl radicals have
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many biological functions under healthy conditions but when a host is infected, the production of
ROS increases (30). During IV infection, ROS play a variety of damaging roles. Viral-infected
epithelial cells will undergo apoptosis via ROS signaling releasing virions into the periphery and
destroying tissue (29, 30). ROS can also play roles in damaging rather than killing epithelial
cells. Free hydroxyl radicals can remove electrons from lipids (lipid peroxidation) thereby
weakening and damaging cell membranes, deactivate cellular co-enzymes or co-factors
necessary for cellular maintenance, and damage both DNA and RNA inside of cells (29, 30). All
of these processes drive epithelial cells closer to apoptosis and throughout the course of IV
infection, lead to massive amounts of epithelial cell damage and cell death.
Neutrophil extracellular trap (NETs) formation also contributes to acute lung damage
during IV infection, albeit indirectly. NETosis is the process by which dying neutrophils release
their DNA containing antimicrobial peptides into the periphery in an effort to “catch” bacteria
and cellular debris (28). In the context of IV infection, NETosis serves to produce mucous and
cellular debris from dead neutrophils (28). NETs become entangled with alveoli which further
leads to endothelial damage of the airway epithelium (28, 30). Also, when MPO is inhibited in
neutrophils, NET formation decreased in influenza-infected lungs, suggesting that the generation
of ROS via MPO is important in NETosis, again indicating the neutrophil’s function in influenza
immunopathology (30).
Natural killer (NK) cells are aptly named after their ability to induce apoptosis in cells
without activation steps (31). Through the recognition, or lack thereof, of MHC I molecules on
the surface of stressed or infected cells, NK cells can directly induce apoptosis or redirect cell
lysis (31). NK cells accomplish this goal by secreting granzymes in close proximity to their
target cell (31). Perforins and other proteases puncture cell membranes allowing for osmotic lysis
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to occur (31). During IV infection, this can result in an increase in the release of virions from a
lysed rather than a cell that has undergone apoptosis. As it relates to the early immune response,
NK cells are activated and trafficked into the infected lungs during an IV infection very early
(31). Within three days of the beginning of the infection NK cells begin to mount an immune
response (31). The early presence of NK cells makes them incredibly important in limiting an IV
infection but there are several key evasion mechanisms IV possesses that allow them to continue
the infection (31).
Influenza virus evades NK cells through direct infection or through the secretion of
unbound HA (32). In the same manner as epithelial cell infection, HA of IV attaches the virion to
sialic acid residues on the surface of NK cells (32). The virion then binds to the sialic acid
residue, docks at the cell surface, and comes in close proximity such that the cell membrane of
the NK cell fuses with the virion’s envelope (32). The IV infection proceeds in the same manner
in NK cells as epithelial cells. Free HA, that being not bound to influenza virions but is released
from infected cells, can also inhibit NK cell cytotoxicity (32). Through the binding and
subsequent internalization of HA into the cell, HA decreases NK cell cytotoxicity mediated by
the downregulation of the zeta chain through the lysosomal pathway (32). The dysregulation of
early NK cell signaling via the zeta chain diminishes the ERK pathway which is essential for
granule production and exocytosis from the NK cell (32). While NK cells play a large role
during the early stages of IV infection, they, along with other early innate cells often times cause
more damage to the upper respiratory and lung epithelium.
Macrophages monocytes, and neutrophils comprise the largest group of innate cells
recruited during the early stages of an IV infection. Macrophages and monocytes are capable of
triggering apoptosis cascades in IV-infected epithelial cells via apoptosis-inducing ligands,
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secrete potent pro-inflammatory cytokines that further the damaging inflammatory response, and
phagocytose cellular debris (26-29). Neutrophils are not only able to phagocytose debris, but
they also produce ROS and enzymes that can directly damage epithelial cells and induce
apoptosis (30). Further, NETosis may result in damaging of endothelial cells and produce
mucous that primes the lungs for ARDS. NK cells also induce apoptosis, and sometimes lysis, of
epithelial cells thereby resulting in damage to the lungs. The early innate immune response not
only shapes the adaptive immune response but also determines the extent of the damage the
lungs and upper respiratory tract will face. Until the adaptive immune response begins to control
the infection, the damage caused by the innate immune response may be lasting and have adverse
effects after the clearance of the virus in the form of bacterial adherence, colonization, and superinfection.

Adaptive immune response
The innate immune response is comprised of the first cells to respond to a viral infection.
During an influenza virus infection, pandemic strains or less virulent seasonal strains, viral
clearance may be dependent on not the innate immune response, but the adaptive immune
response. The adaptive immune response mediates both cellular and humoral immunity (33).
Cellular immunity is derived from various subsets of T cells where activation via antigen
presentation is required in the case of CD4+ T cells or direct cell lysis via cytotoxic CD8+ T cells
(33). Humoral immunity stems from antibody-secreting B cells (34). The modulation of the
adaptive immune response is dependent on the infectious agent, the innate immune response’s
ability to communicate with the adaptive immune response, and time.
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T cell subsets play important roles in mediating the immune response as well as actively
clearing virally-infected cells. CD8+ T cells perform he latter function and induce apoptosis in
infected cells (33, 35). In an effort to control the spread of viral particles and thus, continue the
infection, CD8+ T cells patrol the lungs and initiate contact with MHC class I (MHC I)
molecules presented on the surface of the respiratory epithelial cells (33, 35). Under homeostatic
conditions, non-immune cells and immune cells alike express self-antigens on MHC I molecules
as a signal to CD8+ T cells that they are alive and healthy (33, 35). Should the antigens expressed
on MHC I molecules be abnormal or viral in origin, the CD8+ T cell that comes into contact with
it will release granzymes, perforins, and several serine proteases that induce apoptosis (33, 35).
CD8+ T cells also express the ligand, Fas (FasL) (35). FasL interacts with its receptor, Fas, on
the surface of cells and recruits the death-associated signaling complex (DISC) which further
interacts with the death domain, FADD (35). Activation of DISC results in the specific cleavage
of procaspases into apoptotic effector caspases (35). Through these mechanisms, CD8+ T cells
control the spread and replication of IV.
CD4+ T cells do not directly induce cell death in virally infected cells but rather, they
coordinate the immune response against a specific threat. Professional antigen presenting cells
(APCs), dendritic cells and macrophages, internalize viral antigens they encounter via
endocytosis and travel to secondary lymph organs to encounter naïve CD4+ T cells (33, 36).
CD8+ T cells are restricted to MHC I recognition while CD4+ T cells are restricted to antigens
presented on MHC class II (MHC II) molecules (33, 36). When IV antigens are processed and
loaded onto MHC II molecules on the surface of APCs, and through cos-stimulatory surface
ligand-receptor interactions coupled with cytokine signals, naïve CD4+ T cells become activated
against the presented antigen (33, 36). Helper T cells then coordinate with the innate immune
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response and secrete cytokines that further the pro-inflammatory immune response or dampen
the immune response depending on the lung micro-environment and the cytokines that are being
produced by the multitude of immune and non-immune cells (33, 36). There are also a variety of
T helper cell subtypes that play important effector roles during IV infection.
Th1, or type 1 helper T cells, elicit a cell-mediated response against intracellular
pathogens, namely bacteria and viruses (37). Polarization of Th1 cells stems from recognition of
IL-12 which activates the transcription factor, T-bet (37). T-bet is the hallmark transcription
factor of Th1 cells. Once T-bet has been activated and the naïve T cell has polarized to a Th1
phenotype, Th1 cells begin to secrete IL-2 and IFN- which activate macrophages, CD8+ T cells,
and stimulate B cells to class switch and produce IgG (37). All of these cell types are indicative
of a pro-inflammatory response against intracellular pathogens.
Th2, or type 2 helper T cells, are activated in response to parasitic or helminth infections.
In a similar fashion to Th1 cells, specific cytokines activate naïve T cells and polarize them into
the Th2 phenotype via the induction of transcription factors. For Th2 cells, IL-2 and IL-4
recognition upregulates GATA3, polarizes T cells into the Th2 lineage, and subsequently begins
to secrete IL-4 and IL-10 (38). Th2 cells activate eosinophils, mast cells, basophils, and IgE
production from B cells to combat helminth infections (38).
In the context of influenza virus infections, a Th2 response is observed only for IL-4 and
IL-10 production as these cytokines are anti-inflammatory and serve to negatively regulate a proinflammatory response (39). A Th1 response is much more common during IV infections and as
a result, monocytes, macrophages, and CD8+ T cells become activated and induce damage to the
epithelial cells in the lungs as noted earlier (26). However, there are other T cell subsets that play
large roles during influenza virus infections.
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Th17 cells secrete the effector cytokine, IL-17 (40). Upon recognition of damageassociated molecular patterns by Toll-like receptors or the cytokines, IL-6 and TNF-α, Th17 cells
become activated (40). This activation of Toll-like receptors activates the transcription factor
RORγt to increase expression of the gene, RORC (40). RORC encodes for the production of IL17 which, once produced, is secreted from the cell. The secretion of IL-17 marks the beginning
of a proinflammatory immune response against an infection. IL-17 is secreted from Th17 cells to
assist with both autocrine and paracrine signaling in the environment (40). Inflammatory
monocytes and macrophages that either reside in the location currently infected or recruited via
secreted chemokines have receptors necessary for IL-17 activation as well as any other proinflammatory molecules that detail their course of action. Once IL-17 binds the IL-17 receptor,
the inflammatory immune response against IAV begins.
There are six different cytokines in the IL-17 family (40). These are IL-17A, IL-17B, IL17C, IL-17D, IL-17E, and IL-17F (40). Each cytokine binds to its respective receptor (IL-17RAIL-17RF) but not exclusively. For example, IL-17RA binds to the heterodimer IL-17RA and IL17RC. IL-17F can also bind this heterodimer (41). IL-17C binds the heterodimer IL-17RA and
IL-17RE while IL-17E binds the heterodimer IL-17RA and IL-17RB (41). The receptors for IL17B and IL-17D have not been fully elucidated. Furthermore, while homodimers of IL-17
receptors exist, it is through heterodimer receptors IL-17 activates a proinflammatory response
(41). While subtle differences between each IL-17 isoform and IL-17 receptors are currently
being studied, each cytokine and receptor share varying degrees of sequence homology. The
similarities between each cytokine allow for variable binding on heterodimer receptors while
heterodimer receptors are favored over homodimers in order to tailor the inflammatory immune
response to the extracellular milieu.
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Review of the NF-κB Signaling Cascade
IL-17A activates the NF-κB signaling cascade which is one of the largest and most rapid
signaling cascades associated with the immune response (40-42). NF-κB responds rapidly to
changes in the environment in the form of cytokines, free radicals, and/or pathogenic antigens
recognized by the cell (42). Because of the rapid induction of the NF-κB pathway, it is the first
cellular response to harmful pathogens and thus, the outcomes of NF-κB induction have
consequences for the overall immune response. Due to the extent in which IL-17A activates NFκB through the IL-17RA/IL-17RC heterodimer, it will be used to discuss the NF-κB pathway
and the consequences of NF-κB activation (40-42).
IL-17A binding to IL-17RA has been found to be insufficient to begin the signal cascade
for pro-inflammatory cytokine production (40-42). Therefore, once IL-17A binds to IL-17RA, the
affinity for heterodimerization increases and IL-17RC binds to IL-17RA to enhance the signal
from IL-17A (40-42). At the C terminus of the IL-17RA/IL-17RC heterodimer complex is a
conserved region, termed similar expression of fibroblast growth factor genes and IL-17 receptors
(SEFIR) (43). Included in the SEFIR domain is a coiled-coil loop that is essential for IL-17RA/IL17RC and the first effector molecule in the cascade to bind (43). The C terminus end also consists
of many variable polar amino acids further providing IL-17 receptor and the first effector binding.
The first effector of the IL-17 cascade is NF-κB Activator 1 (Act1) which also contains a SEFIR
domain on its C terminus (44). Through the coiled-coil loop on the IL17A receptor, Act1 can
recognize and bind to the C terminal end of the IL-17A receptor (44). Through X-ray
crystallography of the IL-17RB receptor, leucine 419 and leucine 422 residues on the SEFIR
domain of the cytokine receptor are responsible for the IL-17 receptor and first effector interactions
(44, 45). As for Act 1, leucine residues 474, 475, 477, and tyrosine 478 of the SEFIR domain on

49
Act1 are responsible and critical for their interactions which begin the signal cascade (44, 45). To
stabilize the association between the C terminus ends of the IL-17 receptor heterodimer and Act1,
heat shock protein 90 (Hsp90) binds to both at the plasma membrane (45). Act1 acts as a client
protein for Hsp90 and there is evidence that Act1 and IL-17 receptor binding is drastically reduced
in the absence of Hsp90 (45, 46). Once Act1 has bound to the IL-17RA/IL-17RC receptor on the
cytoplasmic, C terminal end, there are two pathways in which IL-17A signals for a proinflammatory response; one pathway stabilizes newly transcribed mRNA and the other induces
the activation of NF-kB to move into the nucleus and begin the transcription of pro-inflammatory
genes (46, 47).
Once Act1, mediated by Hsp90, binds to the IL-17 receptor heterodimer, IkB Kinase
(IKKi) can phosphorylate Act1 which activates several of its catalytic residues along the protein
(48). Both IL-17A pathways are dependent on the phosphorylation state of Act1 where one
pathway is activated when Act1 is phosphorylated while the other pathway is only activated when
Act1 is dephosphorylated (48). IKKi is a major kinase in inflammation where it also serves two
roles that will be discussed below. The major catalytic domain of Act1 is the U box consisting of
roughly 55 amino acids (47, 48). Prior to the phosphorylation of Act1 by IKKi, the U box domain
remains active due to the conformational status of Act1 when it is de-phosphorylated and Act1 can
act as an E3 ubiquitin ligase while interacting with TRAF6 (49). Act1 ubiquitinates lysine residues
at position 63 of TRAF6 and other proteins in order to facilitate further protein-protein interactions
along the pathway. In order for the signal pathway to continue and activate NF-kB, TRAF6 must
be polyubiquitinated at the lysine 63 position (50). Once TRAF6 has been poly-ubiquitinated, it
becomes activated and can further interact with TRAF6-dependent TGF-β-activated kinase 1
(TAK1) (51). It is important to note that Act1 can ubiquitinate many TRAF6 molecules prior to
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phosphorylation by IKKi thus, TRAF6 acts as the second messenger and amplifies the proinflammatory signal in the IL-17A pathway (49-51).
TAK1 is a member of the mitogen-activated protein kinase (MAPK) family that is activated
by IL-1, tumor necrosis factor, and pathways through Toll-like receptors (including IL-17
receptors) (52). TAK1 binding proteins 2 and 3 (TAB2 and TAB3 respectively) associate with
TAK1 as adapter proteins and are vitally important for TAK1 interactions with the
polyubiquitinated TRAF6 complex (52). Once TAK1 and its adapter proteins interact and associate
with TRAF6, TAK1 begins the canonical inflammation pathway which activates NF-kB for
translocation into the nucleus (52). TAK1, being a kinase, phosphorylates IKKi, the same protein
that was responsible for Act1 phosphorylation (52, 53). IKKi, once phosphorylated,
phosphorylates Inhibitor of kappa B (IkBa) (53). During cell homeostasis, NF-kB is bound to IkBa
which forms a protein complex that inhibits both NF-kB activation and translocation into the
nucleus (53). Tight regulation of TAK1 phosphorylation of IKKi and subsequent phosphorylation
of IkBa are necessary to prevent the activation of unnecessary inflammatory cytokines. Once IkBa
is phosphorylated, it becomes an activated phosphoprotein and dissociates from NF-kB which is
subsequently free to translocate into the nucleus and activate pro-inflammatory transcriptional
machinery. Once inside the nucleus, genes that code for various pro-inflammatory cytokines (IL6, TNFa, COX2, and GM-CSF) and chemokines (CCL2, CCL7, CXCL1, CXCL2, CXCL5)
become upregulated and are transcribed at the behest of NF-kB (54-56). Several genes for tissue
remodeling to allow for immune cell recruitment and aid immune cells’ ability to move through
tight junctions are also upregulated by NF-kB through the IL-17A signal cascade (40, 41, 57, 58).
However, a major problem with IL-17 signaling of NF-kB becomes readily apparent. IL-17A is a
very weak NF-kB activator and the transcripts produced are unstable and readily degraded in the
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cytosol after they have been released from the nucleus. In order to solve this problem, Act1
activates a second branched signaling pathway (59).
The phosphorylation of Act1 by IKKi after Act1 associates with the IL-17 receptor
heterodimer through their SEFIR C terminus domains occurs at serine 311 (59). Once this position
has been phosphorylated, Act1 undergoes a conformational change that allows for TRAF2 and
TRAF5 to bind but excludes TRAF6 (59). The docking and binding of TRAF2 and TRAF5 to Act1
forms an arginine and serine-rich splicing factor SRSF1 (59). SRSF1 prevents the human splicing
factor, ASF, from binding to the 3’ untranslated regions of cytokine and chemokine mRNAs in the
cytoplasm (59, 60). By splicing ASF, pro-inflammatory mRNAs will not be degraded in the
cytoplasm, rather, they will be translated at the endoplasmic reticulum, shuttled to the Golgi
apparatus, and secreted out of the cell to serve their role in the immune response against IAV (6163). Furthermore, the Act1/TRAF2/TRAF5 protein complex activates HuR, an RNA-binding
protein that facilitates mRNA translocation from the nucleus to free ribosomes and then to the
endoplasmic reticulum for translation (64). It is important to note that the Act1/TRAF6/TAK1
complex and the Act1/TRAF2/TRAF5 complex are independent and distinct from one another.
During an immune response to an invading pathogen, other pro-inflammatory cytokines interact
with immune cells and stimulate similar cascades that translocate NF-kB from the cytoplasm into
the nucleus by cleaving IkBa (66, 62, 63, 65). The IL-17A cascade is important for an immune
response because, while IL-17A is not the most potent activator of NF-kB, the
Act1/TRAF2/TRAF5 complex stabilizes mRNA produced by NF-kB translocation.
The coordinated and highly regulated immune response to an invading extracellular or
intracellular pathogen requires highly complex and intertwined signaling cascades in order to
ensure the proper cytokines are produced and the concentration of cytokines produced does not do
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more harm than good. In order to regulate the IL-17A inflammatory cascade, other cells and signals
effectively dampen, then inhibit the cascade. The main mechanism by suppression of IL-17A
signaling is through T regulatory cells (Tregs) (66, 67). Tregs prevent T cells (like Th17 cells)
from staying constitutively active after an immune response has been resolved (66, 67). Tregs
secrete specific immune cytokines, like TGF-β and IL-35, or directly interact with surface
receptors on activated T cells which signal for the ongoing pro-inflammatory cascades to cease
(66-69). The mechanisms by which these surface receptors signal is currently under intense study.
However, it has been hypothesized that Tregs induce a negative feedback mechanism that
constantly signals for the resolvent of pro-inflammatory signals as well as downregulates proinflammatory surface receptors, like IL-17 receptors (66-69). The lack of surface IL-17 receptors
interferes with mRNA stabilization complexes and thus, pro-inflammatory mRNA would be
cleaved in the cytoplasm faster than it would be produced thereby inhibiting pro-inflammatory
signals. Beyond Tregs, there are other proteins in the IL-17A cascade that also inhibit NF-kB
translocation into the nucleus as well as prevent the stabilization of pro-inflammatory mRNA
transcripts.
The polyubiquitination of TRAF6 by Act1 acts as a major regulatory step in the IL-17A
pathway. Deubiquitinating enzymes serve to control the rate in which TRAF6 proteins are
ubiquitinated (70). Several deubiquitinating enzymes exist in the IL-17A pathway. The major
deubiquitinating enzyme is ubiquitin-specific protease 25 (UPS25) (70, 71). UPS25
deubiquitinates both the TRAF2/5 complex that stabilizes pro-inflammatory mRNA transcripts as
well as TRAF6, the second messenger in the NF-kB activation pathway (72). A second
deubiquitinating enzyme, A20, has been suggested to be a critical negative regulator of the NF-kB
pathway by deubiquitinating TRAF6. Outside of deubiquitinating enzymes, the IL-17-dependent
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micro-RNA, miR-23b, also regulates the activation status of NF-kB (73). In particular, miR-23b
targets the mRNA of TAB2 and TAB3 that associate with TAK1 in the MAPK family (73). As
noted earlier, TAK1 association with the polyubiquitinated TRAF6 complex is unstable and will
not result in the activation of downstream effector proteins unless TAB2 and TAB3 are associated
with TAK1. Furthermore, miR-23b also degrades IKKi mRNA which results in the inhibition of
stabilizing pro-inflammatory mRNA transcripts as well as cleavage of IkBa from the NF-kB
complex (74). Through these mechanisms, the IL-17A pathway can be highly regulated by varying
degrees of specificity in order to ensure the pro-inflammatory response can be controlled over
time. However, the regulation of the pathway exists beyond deubiquitinating enzymes and micro
RNA molecules.
In order to prevent Act1 from interacting with the SEFIR domain of IL-17RA prior to
heterodimerization with IL-17RC and binding of IL-17A, TRAF3 inhibits the formation of the IL17 receptor/Act1 complex (75). TRAF3 has been shown to inhibit the Act1/TRAF2/TRAF5
mRNA stabilization branch of the IL-17A signal cascade (75). As for the IkBa cleavage for NFkB trans-localization pathway, TRAF4 acts as a competitive inhibitor of the TRAF6 binding site
thereby preventing TRAF6 binding to TAK1 and TAK1 becoming activated (75, 76). An odd form
of regulation is a direct, third signal from the IL-17RA/IL-17RC dimer itself (77). IL-17A
signaling leads to the dual phosphorylation of C/EBPβ via the ERK pathway at residues threonine
179 and threonine 188 of C/EBPβ (77, 78). C/EBPβ regulates cellular metabolism and proliferation
during an immune response (79). The inhibition of C/EBPβ stops signals to transcription factors
in the nucleus that signal for continuous pro-inflammatory cytokine production.
The discussion regarding IL-17A and the induction of pro-inflammatory cytokines and
chemokines through the IL-17 receptor cascade has been limited to only IL-17A. IL-17B, IL-17C,
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and IL-17F all have similar pathways compared to IL-17A where NF-kB is released from IkBa via
phosphorylation and subsequently translocates into the cytoplasm to induce the transcription of
pro-inflammatory cytokines. IL-17C differs slightly in that interferon-stimulated genes are also
upregulated in response to IL-17C binding to the heterodimer receptor complex, IL-17RA/IL17RE (80). IL-17B induces the NF-kB pathway through the homodimer, IL-17RB (81). The fifth
member of the IL-17 family, IL-17D, is thought to play a role in myeloid cell differentiation but
evidence supporting this hypothesis is lacking and the true nature of IL-17D is unknown (82). The
last IL-17 family member to be discussed has the least sequence homology to any other member
of the IL-17 family and acts as more of an eosinophil recruitment cascade (83). IL-17E signals
through the heterodimer complex: IL-17RA/IL-17RB (83). This receptor complex is found mainly
in the kidneys, liver, and brain of mammals and upon cytokine-receptor recognition, a type 2
allergic response ensues (83). Stimulation of IL-17RA/IL-17RB with IL-17E initiates a similar
cascade seen by IL-17A where Act1 binds to the heterodimer receptor complex and ubiquitinates
TRAF6 (83, 84). TRAF6, most likely through a similar mechanism seen in IL-17A signaling, uses
the MAPK and NF-kB pathways to upregulate the transcription of IL-4, IL-5, and IL-13 (85, 86).
While hypothesized, this pathway for IL-17E has yet to be fully described. A second pathway that
has been implicated in Th2 responses to large pathogens through IL-17E signaling, but has also
not been fully elucidated, is a pro-apoptotic pathway through TRADD, FADD, and subsequent
caspase cleavage (87). While a pro-apoptotic pathway for IL-17E in epithelial cells, macrophages,
and immune cells after an infection has been hypothesized, the mechanism for this needs to be
further understood.
Interleukin 17 is a vital and potent inflammatory activator in the immune system. It bridges
the boundary between the innate and the adaptive immune system to help T cells coordinate a
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response to pathogens while simultaneously activating neutrophils and macrophages to target
infected cells (88). While inflammation is sometimes viewed to be a negative side effect during an
infection, a lot of research has shown that IL-17-dependent inflammation is one of the most potent
activators of inflammation and thus, one of the most important activating cytokines in the immune
system. IL-17 signaling is responsible for inducing inflammation in such a way that its own
signaling also acts as a negative regulator (89). By this method, IL-17 ensures the cell and/or
system returns to homeostasis after infection by inhibiting the pathway it signals through.
However, Th17 and innate lymphoid cells have been directly implicated in autoimmune diseases
and inflammation dysfunction during infections (90). While the IL-17A pathway has been
elucidated to an extensive degree, the role other IL-17 isoforms play during an infection and how
they are regulated during homeostasis is an issue that is currently being studied. Discerning the
pathway by which IL-17 activates other immune cells has proven to be of utmost importance in
our understanding of how inflammation acts as a double edge sword to both assist in immune cell
recruitment during an infection and how inflammation can result in inflammatory diseases.
For resolution and containment of an immune response, regulatory T cells (Tregs) become
activated through the recognition of transforming growth factor- (TGF-). TGF- activates the
transcription factor, FOXP3, which increases the production of the anti-inflammatory cytokines
IL-10 and IL-35 (66, 67, 68, 69, 91). During an influenza virus infection, these cytokines help to
limit the production of pro-inflammatory cytokines like TNF-, FIN-, IL-1, and IL-6 (91, 92).
Further, Tregs secrete Granzyme B which has the ability to induce apoptosis in effector T cells
and pro-inflammatory cells further limiting the pro-inflammatory immune response (91, 93). The
role in which Tregs play during an influenza virus infection, specifically the timing of their
activation and when they limit the robust immune response requires further study.
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At the end of the infection, activated CD4+ T cells will become memory cells and become
immediately activated against exposure to the antigen in the future (91-93). Further, CD4+ T
cells will coordinate with B cells in order to provide the robust and neutralizing humoral immune
response (94).
B cells are capable of recognizing viral antigens in a T cell-independent manner and
produce pro-inflammatory cytokines in response (94). They will also secrete IgM, the pentameric
and low-affinity antibody against that antigen (94). However, T cell-B cell interactions are
required for B cells to undergo class switching and somatic hypermutation (94, 95). In this
respect, the CD4+ T cell response directly influences the B cell response. Through somatic
hypermutation, B cells become more specific against the antigen of interest (94, 95). Then, class
switching from IgM to the high affinity IgG will occur (94, 95). Innate immune cells and
complement recognize the Fc portion of IgG molecules that are bound to antigen and further
their activation and viral clearance (96). Much like activated CD4+ T cells, at the end of the viral
infection, a small population of activated B cells will become memory B cells and reactivate
during future infections against the same pathogen and stop the infection before it can cause
damage (97).
The adaptive immune response is vitally important for clearance of virally-infected cells
as well as tailoring the immune response to be anti-viral in nature. Memory adaptive cells ensure
that subsequent IV infections do not occur and provide robust immunity against IV (98).
However, the serotype of IV is constantly changing in part due to the high fidelity of its RNAdependent RNA polymerase and its multipartite genome. The adaptive immune response
provides specificity against an ongoing IV infection but, much like the innate immune response,
often times damages the host in order to clear the pathogen.
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Immune cell mediated lung damage: the dark side
Directly inducing apoptosis in virally infected cells contributes to the inhibition of viral
propagation and spread during an infection (99). While the immune response may successfully
clear the virus, the indirect and direct damage that is caused can often times be more devastating
than the viral infection. Macrophages, monocytes, and CD8+ T cells can induce cell death in
epithelial cells which dysregulates the respiratory epithelium and promotes damage to the
underlying basolateral membrane (100). Cell apoptosis also promotes the production of DAMPs
in the lung (99, 100). This furthers the pro-inflammatory immune response and the damage to the
epithelial cells in the lungs continues. As the respiratory epithelial barrier becomes damaged and
dysregulated, the subsequent growth and proliferation promotes scarring and impacts the
respiratory function of the lungs (99-101). Infection in the smaller alveoli of the lungs has a
drastic impact on gas exchange and breathing in the host (99-101). Damage and scarring to the
alveoli often times impact respiratory function in the host long after the viral infection is cleared.
Even without long-term architecture changes in the lungs, acute respiratory distress syndrome
via fluid build-up in the lungs is also mediated by immune cells (102). As epithelial cells secrete
cytokines to alleviate the viral infection, fluid begins to build up in the lungs (102). Neutrophils
exacerbate this phenomenon through NETosis and cytokine production (102, 103). While the
immune response is vital for clearing an influenza infection, it can often times be overzealous
and mediate much of the damage done to the host.

Inflammation of epithelial barrier crosstalk
The interface of host-pathogen interactions is usually characterized as a disease followed
by the reciprocal immune response. While true, this paradigm neglects the interactions of non-
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immune cells with immune cells in response to an infectious agent. The first line of defense
against any infectious agent is the host’s barrier; the skin, intestinal epithelium, and respiratory
epithelium (102-104). During an IV infection, the respiratory epithelium plays a large role in
modulating the immune response against the viral infection (102-104). This is accomplished
through early and robust recognition of viral components via PRRs, secretion of migratory
chemokines, and direct ligand-receptor interactions with immune cells (105). However, the
consequence of crosstalk between immune cells and the respiratory epithelium can have
detrimental effects. Previously, we have addressed the role the host’s immune response plays in
causing damage during IV infection via cytokine production, direct cell lysis, and cell death.
Recent evidence has suggested that the modulation of the respiratory epithelium during acute
lung infection via immune cell—epithelial barrier cross talk is also a site of host damage and
might be a potential target for therapeutic intervention (105, 106).

The respiratory epithelium: first line of defense
The major epithelial cell types in the respiratory tract are ciliated, columnar, secretory,
basal, and undifferentiated (107). The architecture of the respiratory epithelium is a function of
the location in the airway. The upper respiratory epithelium is composed of ciliated
pseudostratified columnar epithelial cells that are anchored to the basement membrane of the
extracellular matrix (107, 108). Moving deeper into the lungs, the epithelial cells change from
columnar to simple cuboidal epithelial cells and then to simple squamous epithelial cells in the
alveolar ducts and alveoli respectively (107-109). The simple cuboidal epithelial cells of the
alveolar ducts serve connect respiratory bronchioles to the alveolar sacs containing the alveoli
(107, 110). The simple squamous epithelial cells that comprise the alveoli exist to diffuse oxygen
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across the cell membrane and release carbon dioxide from the capillaries back into the alveoli to
be breathed out and released from the body in a process termed gas exchange (107, 110). As a
whole, the respiratory epithelium plays a role not only in gas exchange but is the lung’s central
defense against pathogens and damaging chemicals inhaled from the environment (1107-110).
Many foreign particles and pathogens, damaging and non-damaging alike, are inhaled
and deposited into the lungs. In order to remove these objects before they can cause lung
damage, the mucociliary transport mechanism acts as a self-cleaning escalator to remove the
debris (111). Airway surface liquid (or epithelial lining fluid) is composed of a sol layer and a
gel layer (111, 112). The sol layer surrounds the epithelium in the respiratory tract while the gel
layer sits overtop, bathing the respiratory epithelium in mucous (111, 112). Mucous is 95% water
with the remaining 5% being comprised of proteoglycans, lipids, other proteins, and DNA
(mucous composition) (112). Submucosal glands and goblet cells in the respiratory tract secrete
mucous and serve to trap foreign particles before they reach the deeper, more fragile regions of
the lungs (111-113). Mucociliary transport is both mucous productions coupled with the beating
of cilia on the columnar epithelial cells in order to remove debris and protect the lungs of the
host (111-113).
As mentioned earlier, the tissue tropism of IV favors cells with sialic acid residues on
their cell surface. Therefore, the ciliated columnar epithelial cells in the upper respiratory tract
are the predominant cell type influenza virions infect (114). The cilia that are responsible for
continuously moving debris and mucous out of the lungs decrease in number as the columnar
epithelial cells undergo apoptosis or stop producing their normal surface proteins due to the viral
infection. Mucous production also increases during viral infection as goblet cells upregulate the
MUCIN genes responsible for mucous production (115). This poses a problem as the mucous
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cannot be cleared via the cilia as efficiently prior to viral infection and leads to an increase in
coughing (115). Coughing serves to forcefully eject mucous-ridden debris from the lungs which
can be damaging and debilitating if it continues for a prolonged period of time. The changes in
nominal functions of the respiratory epithelium are examples of ways in which the epithelial
framework in the lungs become dysregulated (115). In order to limit the damage to the host
through the loss of columnar epithelial cells and the increase in mucous production, the
respiratory epithelium finds ways to communicate with the immune response against viral
infection.
The respiratory epithelium is the first major class of cells to recognize the IV infection
(116). Through the utilization of toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and
NOD-like receptors (NLRs), the columnar epithelial cells recognize various conserved portions
of IV which elicits a specific anti-viral response (116-118). Viral RNA is a major target of
intracellular TLRs and as such, TLR3, TLR7, and, in humans, TLR8 are used to recognize either
single stranded RNA or double stranded RNA (116, 119). TLR3 is expressed both on the cell
surface and in early endosomes (the compartment by which IV is internalized as mentioned
previously) (116, 119). Through the recognition of double stranded RNA (the intermediate step
of viral RNA replication mediated by the viral RNA-dependent RNA polymerase), columnar
epithelial cells begin to produce the pro-inflammatory cytokines IL-6, TNF- and type I
interferons (119). TLR7 is also a potent producer of IL-6 upon recognition of single stranded
RNA in the cytoplasm of the cell (119). The culmination of these pro-inflammatory cytokines is
the polarization of resident immune cells in the lungs towards an inflammatory and damaging
phenotype.
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RLRs recognize double stranded RNA in the cytosol and activate interferon stimulated
genes (116, 120). Through interactions with the mitochondrial anti-viral signaling (MAVS),
interferon regulatory factors (IRFs) three and seven become activated which increase the
transcription of interferon stimulated genes to induce a pro-inflammatory response (116, 120). In
fact, when MAVS signaling is abolished, the levels of interferon drastically drop indicating the
viral-sensing capabilities of RLRs in alveolar epithelial cells results in the early and robust
interferon response (120). RLRs are also capable of inducing the inflammasome in epithelial
cells via MAVs interactions with CARD9 and the NF-kB pathway (121). The RNA-sensing
capacity of epithelial cells exist in low levels under homeostatic conditions but upon the
recognition of double stranded viral RNA, this recognition mechanism increases to result in a
robust interferon response that further polarizes the immune response to be pro-inflammatory
(120, 121).
The internal recognition of pathogen-associated molecular patterns (PAMPs) or damageassociated molecular patterns (DAMPs) induce the NF-kB pathway to produce immature forms
of IL-1, IL-18, and caspase-1 (122). Recent evidence has suggested that NLR-recognition of the
internalized PAMPs and/or DAMPs leads to the formation of the inflammasome and, often
times, pyroptosis, in epithelial cells (123). Cleavage of pro- IL-1, pro-IL-18, and gasdermin-d
into the active forms of these cytokines which potently induce a pro-inflammatory response to IV
infection (124). Interestingly, studies on the lack of inflammasome signaling in IV-infected mice
have found a reduction in the survival rate and effectiveness of the innate immune response (124,
125). However, much of the information regarding the role of the inflammasome during IV
infection has been done in myeloid cells thus, more work must be done to determine the effects
of the inflammasome in epithelial cells early in IV infection.
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The cytokines produced by epithelial cells are the result of early recognition of IV
infection. These cytokines are meant to send a signal to the resident innate immune cells that
there is a current viral infection occurring. However, the activation of resident innate immune
cells is often not enough to control the infection and thus, the respiratory epithelial cells also
produce chemokines that aid in recruiting more potent innate immune cells as well as cells of the
adaptive immune system (126). For example, the major monocyte chemoattractant, CCL2, is
produced early during IV infection by epithelial cells (126, 127). Monocytes are produced in the
bone marrow and are a major driving force in viral containment and clearance. However, as
noted earlier, monocytes are also major drivers of pathology in IV infection thus, epithelial cell
production of CCL2 early in infection often times results in their own pathology.
The cytokines and chemokines produced by the respiratory epithelium drive a damaging
pro-inflammatory response mediated by monocytes and macrophages during the early stages of
infection and transitions to the adaptive immune response interactions during the waning stages
of infection (126). The recruitment of monocytes directly induces cell death in infected epithelial
cells an dysregulate the intracellular junctions that form the barriers between epithelial cells.
Through this dysregulation, more lung damage occurs as iNOS, ROS, and damaging cytokines
gain access to fragile tissue layers of the lungs (127). The respiratory epithelium is one of the
largest physical barriers against infection and damage. As such, the respiratory epithelium aids in
preventing unwanted or unwarranted communication between cytokines and epithelial cells of
the basal membrane under the respiratory epithelium (107). During IV infection, the intracellular
junctions that create a non-permissive barrier to cytokines breaks down as cells die via apoptosis
or cell-cell interactions (107, 108). Cells of the basolateral membrane underneath the respiratory
epithelium express the receptor for epidermal growth factor (EGF) (107, 128). EGF mediates the
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proliferation, migration and repair after epithelial cell damage (128). Under homeostatic
conditions, the EGF receptor and EGF are spatially separated to ensure the EGF response is
limited (128). As respiratory epithelial cells die, and the intracellular junctions become
dysregulated, EGF and other cytokines gain access to the basolateral membrane and begin the
process of rebuilding the respiratory epithelium (128). However, the new columnar epithelial
cells grown in on scar tissue or around decaying/damaged epithelial cells. The resulting airway
remodeling changes the architecture of the lung and may result in ARDS if the IV infection
continues or enhanced pneumococcal infections as the normally protective barriers were
dysregulated (128, 129).

Therapeutic intervention to epithelial barrier dysregulation
The dysregulation of the respiratory epithelial barrier results in long-term consequences
for the host. Current therapeutic strategies to alleviate this dysregulation as a means to protect the
host have been ineffective (130). After IV infection, the damage that has accrued also allows for
the colonization and subsequent proliferation of commensal bacteria like Streptococcus
pneumoniae (Spn) or Staphylococcus aureus (SA) (131). Much work has been done to protect IV
patients against these bacterial infections but given the large number of Spn serotypes and the
multi-drug resistance in many SA strains, therapeutics have been lacking in effectiveness (131,
132). Kostadinova and colleagues found that knocking out the NLRP3 inflammasome in myeloid
cells further dysregulated the alveolar barrier in the lungs and made the lungs more permissive to
Spn infection (133). Through specific induction of the NLRP3 inflammasome in myeloid cells
during IV infection, it may be possible to persevere the epithelial barrier integrity. Future studies
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in co-infection models of IV and Spn will have to be done to test the efficacy of NLRP3
activation.
Cytokines produced by immune cells and epithelial cells during IV are also targets in
therapeutic intervention. Potent pro-inflammatory cytokines like TNF, Interferons  and , and
Interferon- perpetuate the pro-inflammatory response by activating immune cells. Chemokines
that specifically target damaging cells, like CCL2, CCL5, and CCL7 also damage the integrity of
the respiratory epithelial barrier (134). By potentially blocking and inhibiting the production or
recognition of these molecules, the damage done to the epithelial barrier might be lessened and
long-term damage to the host may be avoided.
Vascular permeability caused by trafficking cytokines, chemokines, and migrating cells is
also consequential during IV infection. Fever during IV infections can lead to cellular and tissue
damage until the virus is cleared. Further, the influx of fluid into the lungs due to the increase in
vascular permeability is a major contributing factor to ARDS (135). Neutrophils and monocytes
migrate to the lungs via increased vascular permeability as well. Spn also utilizes the increase in
vascular permeability to traffic into other organs and induce sepsis. By finding a way to mitigate
the spread of bacteria as well as the massive influx of immune cells into the lungs via the
vascular system would aid in lessening the damage caused during infection.
We sought to merge the concepts of interactions between the respiratory epithelium and
the immune response through influenza virus infection in a testable way. To better understand
the integration of these branches of biology, a review article that details the finer points is
currently under revision from our lab. The goal of the review article is to combine the pulmonary
immunology with influenza virus virology to better articulate the problems both fields face in
limiting acute lung damage during viral infection. In order to begin understanding the gaps in
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knowledge listed above, several studies had to be done to test each hypothesis. The next section
will detail the strategies used to explore many of the gaps in knowledge that have been described
above.
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Chapter 3: Methodology

Introduction
Given our hypothesis that inflammatory monocytes are the driving force behind much of
the immune-mediated epithelial damage in the lungs, assessing the parameters surrounding
monocyte recruitment, lung damage via direct cell-cell interactions or protein-mediated
destruction, and the loss of barrier integrity underlying the respiratory were analyzed. In order to
directly test our central hypothesis, techniques such as immunoblotting, histological analysis of
paraffin embedded mouse lungs single cell suspensions, flow cytometry, and ex vivo cell assays
were performed. Robust statistical analyses were performed at an alpha level of 0.05 to ensure
differences seen between samples were not due to sampling error.

Research design
This study was conducted utilizing hypothesis-driven experimental research to establish a
cause and effect relationship. This was accomplished by testing the central hypothesis using
classical and modern immunological techniques. The basis of the experiments that were
encompassed in the study begin with infection model that was used throughout the study. Mice
on days 4, 7, 10, 14, and 21 were infected with 250 plaque forming units (PFU) of A/PR/8/34
(PR8, H1N1) influenza virus in 100 µL of cold PBS. This volume was chosen to ensure the virus
was delivered not only into the lungs but deep into the small alveoli of the lungs as well. Mice
were monitored every few hours for signs of disease (ruffled fur, hunched over, shallow
breathing). Further, the body weight of each mouse was taken at the same time throughout the
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course of the experiment. Age-matched mice of the same sex were given 100 µL of PBS without
virus at the same time as the infected mice to be used as controls.
For early experiments, the lungs from mice were analyzed on days 4, 7, 10, 14, 21, and
28 in order to determine the time points that coincided with the greatest observed morbidity. On
the day of the experiment, mice were euthanized via carbon dioxide asphyxiation, washed with
70% ethanol to remove contaminants, and the lungs were aseptically removed with sterile
dissection scissors and forceps. Bronchoalveolar lavage (BAL) fluid was collected by inserting a
small catheter into the trachea of the euthanized mouse and washing with 1 mL cold PBS a
minimum of three times. This was performed for cytokine analysis and to assess lung damage.
The large lobe of the lungs was perfused with 1 mL of 4% formalin and then placed into 4%
formalin for 24 hours at room temperature for histological analysis. The three smaller lobes were
placed into 1 mL RNA-Later for RNA analysis, tissue protein extraction reagent with protease
and phosphatase inhibitors for immunoblot analysis, or RPMI-1640 supplemented with 10% fetal
bovine serum (FBS) and 1% penicillin and streptomycin. Once these tissues were collected, the
lobe-specific analysis occurred for flow cytometry.
For RNA sequencing studies, monocytes from mock, WT-PR8, and IFN--/--PR8 were
magnetically sorted and total RNA was extracted. PolyA RNA-Seq libraries were prepared using
a NEBNext Ultra II RNA-Seq library kit. Adapters from the sequencing process were trimmed
and and reads were aligned to a mouse genome (mm10) with HISAT2. Differentially expressed
genes (DEGs) between groups were identified using the R/Bioconductor package DESeq2
v1.24.0 with a significance cutoff of adjusted p-value <0.05 as well as a minimum absolute log2fold change value of 1. Pathway enrichment analysis was carried out using Ingenuity Pathway
Analysis (PMID: 24336805). Canonical pathways were identified with a log10 significance (p-
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value) cutoff of 1.3. Selected pathways and their Z-scores are shown as a bar graph using
ggplot2.

Context of the study
These studies were conducted using C57BL/6 mice or specific knockout mice bred on a
C57BL/6 background. In every experiment, there were even amounts of age-matched male and
female mice for each experimental and control group. For every experiment, control mice
received the same treatment as the experimental mice (light anesthesia via isoflurane) were given
100 µL of PBS instead of 250 PFU of PR8 in 100 µL of PBS. When knockout mice were used,
the same proportion of age and sex matched mice were given 100 µL of PBS instead of 250 PFU
of PR8 in 100 µL of PBS. The knockout mice were compared to C57BL/6 (WT) mice that were
given either PBS alone or PR8. The sample sizes of each group were calculated prior to the
experiment using a power analysis in order to ensure statistically reliability but remain within the
ethical limitations of animal usage.
For flow cytometric analyses, the same flow cytometer (BD Symphony) was used for
every experiment. The antibodies used for flow cytometry were also the same throughout the
studies. The clones and colors of each cellular marker were used and titrated prior to use.

Instrumentation
To assess relative frequencies of inflammatory monocyte populations in the lungs, many
instruments must be used. The primary instrument utilized in these studies was a BD Symphony
flow cytometer. Flow cytometers are powerful machines in that, they can decipher the size,
granularity, and relative fluorescence of single cells as they pass through a capillary tube termed
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a flow cell. In order to determine size and granularity of cells, single cells pass through the flow
tube and disrupt lasers that are adjacent to one another. The time in which one laser is disrupted
can calculate the size of the cell. The adjacent laser is also disrupted at the same time however,
the amount of light that passes through the cell is calculated and this provides the granularity of
the cell. Using both measurements of size and granularity, specific populations of immune cells
can be determined. For example, lymphocytes are relatively large in size, but their nucleus
comprises the vast majority of the cell’s cytoplasm thus, there is little granularity. Conversely,
neutrophils are large cells with a bi-lobed nucleus and thus, are able to be differentiated from
lymphocytes. While these measures are the first important step, flow cytometers are also able to
determine the relative fluorescence intensity of surface receptors on cells or even the relative
fluorescence intensity of transcription factors and intracellular cytokines. To achieve this,
fluorophores, molecules that are excited by specific wavelengths of light, are conjugated to
antibodies that are specific to a surface receptor, transcription factor, or cytokine. As the single
cells pass through the flow cell, their size, granularity, and antibody-specific markers are
measured via lasers that emit the visible spectrum of light. While some flow cytometers have
lasers that can measure fluorophore-conjugated antibodies outside of the visible spectrum of
light, namely UV and IR, the FACS Symphony does not use these lasers.
To ensure the data acquired from the flow cytometer is accurate, a compensation panel
must be performed to minimize spectral overlap as many markers are analyzed simultaneously.
Compensation is the process by which spectral overlap between two or more fluorophores is
teased apart and any overlap between colors is negated. Photons emitted by one fluorophore are
converted into electrons by photomultiplier tubes in order to obtain the emission wavelengths.
However, the photomultiplier tubes can interpret signals from more than one fluorophore. The
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spectral overlap created is what causes false positives or severely skewed data. To overcome this
spectral overlap, compensation of spectral overlap calculates the relative emission of a single
fluorophore without the emission of any other fluorophores. The numerical value of a single
fluorophore is then added to a matrix. This process is then carried for every fluorophore that is
going to be used during an experiment. Once all of the individual emissions have been calculated
and added to the matrix, automatic compensation, as derived by Bagwell and Adams or
Herzenberg et al. is then utilized to calculate spectral overlap and subsequently remove it from
the analysis (1993, 2006). By following these steps, spectral overlap and false positives in the
data acquired by the flow cytometer can be negated and the results trusted.
When compensating samples for flow cytometry, there are several rules that need to be
followed. Initially, the material that is used to compensate samples is extremely important. Either
cells or beads that bind to any and all antibodies can be used to compensate fluorophores for
flow cytometry. With this come a few caveats. For cells, the cells must express the markers of
interest to a relative intensity that will be seen for the experimental samples. If the markers on
the compensation cells are too few or too plentiful, the relative intensity could result in more or
less spectral overlap when examining the experimental samples which would result in false
positives or false negatives in the experimental data. To assess the correct fluorophore emission,
the proper concentration of antibodies to cell markers should be analyzed. When using beads,
there must be strong negative and strong positive populations in order to correctly assess the
relative intensity of each fluorophore. Also, the proper forward scatter area and side scatter areas
must be calculated prior to using beads due to the varying sizes of cells in experimental samples.
Last, the colors of the fluorophores used for any given experiment must match the fluorophores
used in the control samples. For example, a ubiquitously expressed cell surface marker will have
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a very bright emission wavelength and the control must have a similar emission wavelength for
proper compensation.
Another way to compensate for flow cytometry are fluorescence minus one (FMO)
controls. When using multicolor panels, FMOs can be important when setting gates and
calculating spectral overlap using flow cytometry software. FMOs are samples of cells that
contain every antibody in a panel except one. For example, if a panel contains nine colors, there
would be ten FMOs; each lacking a specific color and one sample without any antibodies. These
samples are recorded and after automatic compensation with the compensation matrix, FMOs
allow for precise gating and assurance that there is no spectral overlap in the data.
When performing a flow cytometric experiment with multiple fluorophores, especially
when using fluorophore-conjugated antibodies, compensation must be performed in order to
prevent false positive data. When two fluorophores emit photons at similar wavelengths, some of
this light can spill over into the detector of other fluorophores. This spillover, or spectral overlap,
may result in a false positive and skew the flow cytometry data. To account for this,
mathematical corrections using individual emission spectra collected in a matrix can separate
fluorophores that are very close in emission. Certain fluorophores, however, cannot be fully
compensated (like several brilliant violet colors or APC and PE-Cy7) and should be considered
prior to the experiment, during the design of the panel. Through compensation, the
reproducibility and validity of any flow cytometer can be assured.

Data collection
Data were collected in the same fashion for every experiment. For the primary collection
of mouse tissues, buffers were prepared using the same aseptic procedures the day prior or the
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morning of the experiment. Mock-infected mice were always euthanized first to ensure there was
no contamination between groups and experimental groups (infected) were subsequently
euthanized. One set of dissection tools were used to open the chest cavity of the animal and
another set was used to remove tissues. Prior to the removal of any lung, the dissection scissors
were doused in 70% ethanol. As mentioned previously, bronchoalveolar lavage (BAL) fluid was
collected by inserting a small catheter into the trachea of the euthanized mouse and washing with
1 mL cold PBS several times. This was performed for cytokine analysis and to assess lung
damage. The large lobe of the lungs was perfused with 1 mL of 4% formalin and then placed into
4% formalin for histological analysis. The three smaller lobes were placed into 1 mL RNA-Later
for RNA analysis, tissue protein extraction reagent with protease and phosphatase inhibitors for
immunoblot analysis, or RPMI-1640 supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin and streptomycin. Once these tissues were collected, the lobe-specific analysis
occurred. Single cell suspensions were then performed as noted earlier and only samples that had
a viability of at least 70% were included in flow cytometry studies or cell stimulation-based
studies.

Data analysis
The results from the studies were analyzed to determine the changes, if any, were
witnessed between each experimental and control group of mice. Disease morbidity and disease
mortality were analyzed using linear regression analysis where the slopes of each line were
tested for significance. Non-biased scoring via histological analyses of influenza virus-infected
mice were analyzed by a pathologist not involved in the studies. Statistical analysis between
mock-infected and WT mice was determined using a t-test with an alpha level of 0.05 while a
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one-way ANOVA was used for histological analysis involving more than two groups. A Tukey’s
post-hoc test was then calculated to determine where the statically significant differences, if any,
were found.
For frequencies of monocytes between groups, 100,000 individual cells, or events from
the flow cytometer, were analyzed. The frequency of cell populations acquired from the flow
cytometer were analyzed using the same gating strategy to ensure the analyzed area of cells were
the same. Between mock-infected and WT mice, a t-test with an alpha level of 0.05 was used to
determine statistical significance. When analyzing more than two cell populations, a one-way
ANOVA with an alpha level of 0.05 followed by a Tukey’s post-hoc test was used to determine
if there was any statistical significance among the groups and where the differences between
groups was.
The researcher recognizes that there are assumptions that must be made when using a
one-way ANOVA. A one-way ANOVA may only be used when investigating a single factor and
a single dependent variable. This statistical test is designed to determine if there are any
statistical differences, but it does not determine where those differences are from. To correct for
this assumption, every statistical test involving more than two groups was accompanied with a
post-hoc test to determine where the statistical differences are. Further, the alpha level of 0.05 is
suggestive of differences between groups 95% of the time. In other words, 95% of studies would
find the observed difference. It is possible the null hypothesis is true in each scenario. To account
for this assumption, each experiment was run in duplicate, if not in triplicate, to ensure any and
all observed differences were robust.
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Reproducibility
The experiments that were required months of work and many individual experiments
that were subsequently analyzed to test the central hypothesis. Given the range of time in which
these experiments were performed, the reproducibility of data from one experiment to the next
was of vital importance. Mice were used in compliance of NIH recommendation for use of the
mice published in the guide for the care and use of lab animals. The animal protocol detailing the
procedures and techniques utilized was reviewed and approved by the University of North
Dakota Institutional Animal Care and Use Committee (IACUC) under the protocol 1808-8. Mice
were routinely infected in the morning and subsequently weighed at the same time each
following day. Mice were routinely euthanized in the mornings and tissues were collected in the
same manner for every experiment. Single cell suspensions were performed in similar fashions
from one experiment to the next and the flow cytometer was compensated prior to running any
samples for each experiment. Standard curves and mock-infected controls were included for
every cytokine bead array and the experiments were performed as per the manufacturer’s
directions. By taking these vital steps, the reproducibility of the data and the experiments was
ensured.

Summary
This chapter describes the context, instrumentation, methods, procedures, and the
reliability of each study. Further, the data collection process and the data analysis were also
presented. The data collected was subsequently analyzed following the parameters presented in
this chapter. In the following chapter, the results of the collected and analyzed data will be
discussed. A summary and discussion of the findings, first described in this chapter and
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presented in chapter 4, as well as limitations of the studies, implications for future studies, and
recommendations of future research will be described in chapter 5.
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Chapter 4: Analysis and Presentation of the data

The severe morbidity and mortality associated with acute influenza A virus infection
(IAV) results in $11.2 billion annually to the healthcare system of the United States. Further, the
CDC estimates that as many as 61,000 people die each year in the United States due to IAV
infection. From secondary comorbidities to the induction of cytokine storms within the lungs of
IAV-infected individuals, the role of the host’s immune response in containing, but also
damaging the host cannot be understated.
As mentioned in chapter 2, the exact mechanism by which the innate immune response
promotes a hyper-inflammatory state has been documented but not well defined. Here, we tested
the central hypothesis that the host’s immune response is responsible for the respiratory
epithelium damage observed in acute influenza A virus infection. Further the direct damage to
the lungs during IAV infection is caused by inflammatory monocytes (CD11b+ Ly6C+ CCR2+,
IMs). The purpose of this study was to elucidate the mechanisms by which IMs are recruited
during IAV infection, detail their role in lung pathology, and identify specific pro-inflammatory
cytokines that aid in IM-lung damage.
This chapter begins with an overview of the procedures used to analyze the data acquired
over the course of one and a half years. Many techniques including flow cytometry, histological
staining, cell sorting, RNA sequencing, and mouse work was necessary to test the central
hypothesis. The next section details the reliability of the instrumentation that was used. Namely,
flow cytometry is a very useful and robust instrument but the controls, machine maintenance,
and reliability are all important and vary between users. It is of the upmost importance to ensure
the flow cytometer was accurate and the machine settings were similar across each experiment.
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The third section details the influenza mouse model that was used for each study. There were
many different knock-out mouse strains that were available to test the central hypothesis.
The bulk of this chapter discusses in great detail the data that was acquired from testing
the central hypothesis and the subsequent research questions that branched from one experiment
to the next. There is a total of six research questions that were tested beginning with the
overview of modeling influenza A virus infections in mice and identifying an important
leukocyte that is recruited during the acute phase of the disease. The second research question
tests the importance of these leukocytes on viral clearance and disease severity in knock-out
mice. The third research question is in regard to an antiviral cytokine that plays an important and
novel regulatory role of the aforementioned leukocytes and the fourth research question details
data acquired from RNA sequencing of sorted and isolated monocytes. The fifth research
question tests the source of IFN- during influenza virus infection. The sixth research questions
detail the role of the adaptive immune response in mice and how the innate and the adaptive
immune responses overlap. Together, these data support the hypothesis that an over-zealous
immune response during influenza A virus infection is responsible for much of the pathology
associated with the disease. The end of the chapter provides a summary of the data as they relate
to the research questions.

Data analysis procedures
The researcher performed experiments over the course of one year and half and collected
data from each experiment. Each experiment contained at least two groups, one experimental and
the relevant controls for the experimental group. For some experiments, there were as many as
four groups with an experimental group, a comparison for the experimental group, and the
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relevant control groups. Each group contained at least five mice to ensure statistical power
(detailed in chapter 3). Every experiment was done at least twice for rigor.
The six research questions were examined using descriptive statistics including means
and standard error of the means. The mean provided the central tendency for each variable
studied while the standard error of the mean measured variability between groups for each
distribution. The data with two groups were analyzed using a t-test with an alpha level of 0.05 or
less being statistically significant. Where more than two groups were compared, a One-Way
ANOVA with a Tukey’s post-hoc test for multiple comparisons was used with an adjusted alpha
level of 0.05 or less being statistically significant.

Instrumentation reliability
As noted in chapter 3, the setting for the flow cytometer were optimized prior to each and
every experiment. These optimal settings were saved and used for each experiment. Prior to each
experiment, compensation controls using compensation beads, as well as single cells, were run to
ensure optimal laser distribution. Compensation controls were also used to minimize spill-over
between laser channels. A minimum of 106 cells from each sample of any given experiment
were stained for flow cytometry. 105 cells were collected by the flow cytometer and analyzed

Figure 2. Gating strategy for flow cytometric analysis of single cells from the lungs of mice.
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using FlowJo (Tree Star) software. Figure 1 provides an over view of the gating strategies
employed for each experiment where total alive cells, singlets, and CD11b+ cells were gated.
For cytokine bead array experiments, the setting of the flow cytometer was optimized
prior to each experiment. When determining the concentration of each cytokine/chemokine, the
mean fluorescence intensity (MFI) value from the flow cytometer was compared to the MFI
standard curve of the known analyte.

Animal Model
Six to eight-week-old C57BL/6 mice (B6), or single protein knockout mice on a
C57BL/6 background (CCR2-/-, IFN--/-) were used in compliance of NIH recommendation for
use of the mice published in the guide for the care and use of lab animals. The animal protocol
detailing the procedures and techniques utilized was reviewed and approved by the University of
North Dakota Institutional Animal Care and Use Committee (IACUC) under the protocol 18088. As mentioned previously, control mice were matched in both sex and age. The B6 mouse
model was used for this study for several reasons. B6 mice are the most widely used inbred
mouse strain to model human disease. Further, the B6 mouse is very easy to breed and
inexpensive to house when compared to larger animal models like rats or ferrets (as influenza
virus research has been performed in). These mice are also less sensitive to pain which
minimizes animal suffering and cruelty when infected them with viruses.
Mice were anesthetized via light isoflurane inhalation and given a sub-lethal dose of 250
PFU H1N1 (PR8) intranasally in 100 µL sterile PBS. Control B6 mice were anesthetized and
given only 100 µL sterile PBS. All mice were allowed to eat and drink ad libitum for seven days
post-PR8 infection and monitored for loss of body weight. Seven days or a 20% loss in body

80
weight was considered to be the endpoint for each experiment. After seven days of infection,
mice were euthanized, and their lungs were aseptically collected for protein analysis or flow
cytometric analysis.

Figure 3. Timeline of all infections for mice.

Modeling Influenza A Virus Infection in Mice
Mice were infected with 250 PFU of influenza A virus (IAV) in 100 µL PBS as
previously described. To evaluate the morbidity associated with IAV infection, mice were
euthanized on day 4, 7, 10, 14, 21, or 28 post-PR8 infection. The largest decrease in body weight
was observed between days seven and nine (figure 4). The body weight in PR8-infected mice
was completely regained by day 14 post-infection. To assess the early immune response between
days 4 and 10, inflammatory cytokines were measured. TNF-, IFN-, and IL-6 were all
elevated on days 4 and 10 compared to uninfected mice but these cytokines peaked at day 7
(figure 4) suggesting seven days post-PR8 infection is when the immune system mounts the
largest response. Further, the concentration of CCL2 was highest at day 7 (figure 4).
Hematoxylin and eosin (H&E) staining of the large lobe of the lungs revealed a large influx of
cells infiltrating into the lungs via the large airways at day 7 post-infection compared to mockinfected mice (figure 4). By days 14 and 21 post-infection, the massive cellular infiltration into
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the lungs had been ablated suggesting resolution of the disease by day 14. Due to the highest
morbidity occurring seven days post-infection via percent of body weight lost, the influx of cells
into the lungs, and the inflammatory burden as detailed by cytokine analysis, this time point was
chosen for future experiments.
Due to the high influx of cells into the IAV-infected lungs of B6 mice as shown in Figure

Figure 4. Percent weight change, cytokine analysis for data 4, 7, 10, 14, and 21 post-PR8 infection in mice, and H&E staining of
mouse lungs on days 7 and 21 post-PR8 infection. Data is representative of two independent experiments using 6-8-week-old
sex-matched mice. Six mice per group were used in each experiment. Data are presented as ± SEM. ****p < 0.0001,
***p < 0.001, **p < 0.01, and *p < 0.05 using a one-way ANOVA with Tukey’s post-hoc test for variance.

4, the phenotype of the immune cells was analyzed by flow cytometry. The frequency of
monocytes (CD11b+ Ly6C+) drastically increased on day 7 compared to mock-infected controls
as shown by comparing mock-infected mice and PR8-infected mice seven days post-infection
(figure 5). Further, the increase in CCR2 expression also suggested the influx of monocytes was
pro-inflammatory in nature. As evidenced by figure 4, the time point for inflammatory profiling
in mice was determined to be day 7 due to the increase in pro-inflammatory cytokines. Similarly,
the recruitment of inflammatory monocytes into the lungs was determined on days 4, 7, 10, 14,
21, and 28 post-PR8 infection. The frequency of IMs in the lungs were compared to mock-
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infected mice at each timepoint. In an identical manner to the inflammatory cytokines, the peak
of IM recruitment into the lungs was day 7 with a modest increase at day 4 (figure 5). By day 10,
IMs had returned to levels comparable to mock-infected controls with a trend that continued to
remain low through day 28 post-PR8 infection. (figure 5).

Figure 5. Identification of inflammatory monocytes via flow cytometric analysis. Data is representative
of three independent experiments using 6-8-week-old sex-matched mice. Six mice per group were used
in each experiment. Data are presented as ± SEM. ****p < 0.0001, ***p < 0.001, **p < 0.01, and
*p < 0.05 using a one-way ANOVA with Tukey’s post-hoc test for variance.

To determine if the increase in monocytes were inflammatory or macrophage-like, the
pro-chemotactic, pro-inflammatory receptor, CCR2, was measured on the monocytes via flow
cytometry. CCR2+ monocytes, termed inflammatory monocytes (IMs), were elevated drastically
in PR8-infected mice compared to mock-infected controls (figure 5). Further, more than 50% of
the monocytes in the lungs were CCR2+ suggestive of a robust inflammatory response (figure 5).
Further phenotypic analysis for inflammatory profiling of the IMs in the lungs showed an
increase in CD80 (activation molecule), IL-17RA (pro-inflammatory receptor for IL-17),
CX3CR1 (mediated adhesion of leukocytes in tissue), and CD11c (integrin on macrophages and
monocytes) in PR8-infected mice compared to mock controls (figure 6). These data suggest that
the influx of immune cells into the lungs during acute PR8 infection more closely resemble
inflammatory monocytes and no other leukocytes. Further, the inflammatory profile of these IMs
is suggestive of a hyper-inflammatory response.
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Figure 6. In depth phenotyping of surface receptors on inflammatory monocytes via flow cytometry on days 7, 14, and 21 postPR8 infection. Data is representative of three independent experiments using 6-8-week-old sex-matched mice. Six mice per
group were used in each experiment. Data are presented as ± SEM. ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05
using a one-way ANOVA with Tukey’s post-hoc test for variance.

Lung Pathology of CCR2+ Monocytes: CCR2-/- Mouse Model

To test the hypothesis that CCR2+ monocytes are responsible for the damage to the lung
epithelium, we infected mice deficient in CCR2 with PR8 (CCR2-/--PR8) and analyzed the
recruitment of IMs in the lungs and lung damage via the production of inflammatory cytokines
and chemokines. Previously, the morbidity in mice infected with PR8 resulted in nearly 20%
body loss within seven days of infection. In CCR2-/- mice, the observed morbidity was
statistically less than WT-PR8 mice with total weight loss in CCR2-/- mice being 10% from their
starting weight (figure 7). Further, the infiltration of total immune cells into the lungs was less in
the CCR2-/--PR8 mice compared to the WT-PR8 mice (figure 6) suggesting the reduced weight
loss was due to a less severe immune response. As a control, flow cytometric analysis revealed
that CCR2-/--PR8 mice had a reduction of IMs in the lungs that resembled that of mock-infected
mice (figure 7). Further, the concentration of CCL2 in the lungs was elevated in the CCR2-/--PR8
mice compared to the WT-PR8 and mock mice suggesting the production of CCL2 and thus, the
ability to recruit CCR2+ cells was present in the CCR2-/--PR8 mice but the lack of the CCR2
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receptor did not stop the production of the chemokine (figure 7). Instead of CCL2 being
internalized and by recruited IMs as they migrate to the lungs, the concentration of CCL2 did not
decrease and thus, there was an increase in CCL2 in CCR2-/--PR8 mice compared to WT-PR8
mice (figure 7). These data suggest the CCR2-/- mice were deficient in CCR2 signaling and the
overall morbidity associated with PR8 infection was lessened without inflammatory monocytes.

Figure 7. Percent weight change, H&E histological staining, flow cytometric analysis, and measurement of CCL2 in WT-mock,
WT-PR8, and CCR2 knock out mice seven days after PR8 infection. Pulmonary inflammation observed by H&E staining of mock,
PR8-infected, and CCR2-/--PR8 mice 7 dpi. Data is representative of three independent experiments using 6-8-week-old sexmatched mice. Five to six mice per group were used in each experiment. Data are presented as ± SEM. ****p < 0.0001,
***p < 0.001, **p < 0.01, and *p < 0.05 using a one-way ANOVA with Tukey’s post-hoc test for variance.

Role of IFN- in IAV Immunopathology: IFN--/- Mouse Model
While monocytes may be the cells responsible for lung damage early in IAV infections,
the observed morbidity without CCR2+ cells suggested another mechanism by which IAV
damages the host. During the initial immune surveillance in figure 3, high concentrations of the
anti-viral cytokine, IFN-, were observed (figure 8). To test the role of IFN- during PR8
infection, IFN--/- mice were infected with 250 PFU of PR8 (IFN--/--PR8) and seven days later,
euthanized to assess the immune cells in their lungs as well as inflammatory cytokines and large
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airway damage. IFN--/--PR8 mice lost less than 10% of their body weight at day seven postinfection while WT-PR8 mice lost nearly 20% of their body weight suggesting a damaging role
for IFN- during PR8 infection (figure 7). Further, the early pro-inflammatory cytokines, TNF-a
and IL-1 were decreased in IFN--/--PR8 mice compared to WT-PR8 mice (figure 8). The antiinflammatory cytokine, IL-10, was increased in IFN--/--PR8 mice suggesting less of a robust
inflammatory response in the absence of IFN- (figure 8). The concentration of CCL2 in IFN--/-PR8 mice was also decreased when compared to WT-PR8 mice (figure 8). These data suggest a
shift from the hyper-inflammatory state observed in WT-PR8 mice to a milder immune response
in IFN--/--PR8 mice. To test whether the decrease in CCL2 in IFN--/--PR8 resulted in a
decrease in IMs in the lungs, mice were euthanized seven days post-PR8 infection and single
cells from their lungs were prepared for flow cytometry. The frequency of IMs in the lungs of
IFN--/--PR8 mice was less than that of WT-PR8 mice suggesting IFN- modulates the
recruitment of CCR2+ monocytes from the bone marrow during PR8 infection (figure 8). Taken
together, the data suggest a relationship where IFN- production in the lungs during PR8
infection drives the recruitment of CCR2+ inflammatory monocytes by increasing the production
of CCL2 and subsequently priming IMs to become hyper-inflammatory and damaging to PR8infected epithelial cells. To test whether the lack of IFN- also resulted in a decrease in lung
pathology, large lobes of lungs from mock-infected mice, WT-PR8 mice, and IFN--/--PR8 mice
were fixed with 4% formalin for at least two days, paraffin embedded, sectioned into 5 µm
sections, and subsequently stained with H&E to analyze the infiltration of cells into the lungs in
addition to the pathology associated with large airways. H&E staining revealed a decrease in cell
infiltration in the IFN--/--PR8 mice compared to the WT-PR8 mice. Further, the damage to the
brachial epithelial and endothelial cells in the IFN- lungs was less severe when compared to the

86
WT-PR8 mice (figure 8). Less damage to the pulmonary epithelium when mice are systemically
deficient in IFN- supports the hypothesis that IFN- is a key recruiter of pro-inflammatory cells
and mediates the damage done to the lungs during PR8 infection.

Figure 8. Overview of experiments with IFN--/--PR8 mice. Concentration of IFN- seven days post-PR8 infection in WT mice
suggested a pro-inflammatory role for this anti-viral cytokine. Percent weight change, histological analysis via H&E staining,
flow cytometry analysis of inflammatory monocytes, and concentrations of pro-inflammatory cytokines or anti-inflammatory
cytokines. Data is representative of three independent experiments using 6-8-week-old sex-matched mice. Five to six mice per
group were used in each experiment. Data are presented as ± SEM. ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05
using a one-way ANOVA with Tukey’s post-hoc test for variance.

RNA-sequencing of IFN--Proficient and IFN--Deficient Mice During IAV Infection
The recruitment of inflammatory monocytes to the lungs by IFN- during an influenza
virus infection causes direct damage to the respiratory epithelium. To better understand the
factors that inherently allow IMs to interact with infected epithelial cells, as well as canonical
inflammatory pathways, inflammatory monocytes from uninfected, WT-PR8, and IFN--/--PR8
mice were magnetically sorted. RNA from the magnetically sorted monocytes was extracted and
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RNA sequencing analysis was performed. Principle Component Analysis showed that the sorted
cells clustered within their respective groups thereby suggesting the sorted cells were similar to
their respective group (figure 9).

Figure 9. Principle Component Analysis of magnetically sorted monocytes from WT-Mock, WT-PR8, and IFN--/--PR8 mice seven
day spost-PR8 infection. Five mice, sex-matched and aged 6-8 weeks, were used for RNA-sequencing analysis except the IFN-y
sorted monocytes where four mice were used.

Differentially expressed gene (DEG) analysis revealed each group had a distinct subset of
genes that were expressed during PR8 infection. The largest amount of DEGs was between the
mock and the IFN--/--PR8 monocytes where 1241 genes were differentially expressed (figure
10). Between mock and WT-PR8 monocytes, 469 genes were differentially expressed (figure
10). These data suggest that mice infected with PR8 had genes that were either significantly
upregulated or significantly downregulated when compared to mock mice. The final comparison
between WT-PR8 monocytes and IFN--/--PR8 monocytes revealed 335 DEGs (figure 10) which
suggests that without IFN-, IMs express a different subset of genes. To determine what the roles
of the observed DEGs are, canonical immune pathways were calculated using pathway
enrichment analysis Canonical pathways were identified with a log10 significance (p-value)
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cutoff of 1.3 and determine dot be upregulated or downregulated between groups (mock vs WTPR8, mock vs IFN--/--PR8, and WT-PR8 vs IFN--/--PR8). A wide variety of canonical
inflammatory pathways were significantly decreased between the WT-PR8 and IFN--/--PR8
monocytes (figure 10). Specifically, CCR5 signaling in macrophages, chemokine signaling,
complement fixing, cytotoxic T lymphocyte-mediating apoptosis, inflammasome pathways,
leukocyte extravasation, the NF-kB pathway, and iNOS and ROS production in macrophages
were also significantly decreased in the IFN--/--PR8 monocytes when compared to WT-PR8
mice (figure 10). The drastic reduction in the pathways listed are indicative of an attenuated M1
inflammatory response in the IFN--deficient monocytes as evident by a reduction in these
monocytes’ ability to undergo chemotaxis and recognize inflammatory chemokines, recognize
complement proteins and target opsonized protein for phagocytosis, produce IL-1 and IL-18 via
inflammasome induction as well as type I interferons, and directly damage influenza virusinfected cells via nitric oxide and/or reactive oxygen species production respectively (figure 10).
Together, the DEGs and the pathway analysis revealed a dampened inflammatory response in
monocytes that were not activated in the presence of IFN- compared to monocytes that were
(WT-PR8 monocytes). These data correlate with the in vivo data from research questions two
and three where IMs are activated by IFN- and recruited to the lungs by CCL2 where they
directly decrease the integrity of the respiratory epithelium by committing epithelial cells
infected with influenza virus to undergo apoptosis and by secreting pro-inflammatory cytokines
that further exacerbate the over-zealous anti-viral, pro-inflammatory state.
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Figure 10. Differentially expressed genes between WT-mock, Wt-PR8, and IFN--/--PR8 sorted monocytes on day seven post-PR8
infection and pathway analysis of specific immune-related pathways as shown by changes in Z scores. Five mice, sex-matched
and aged 6-8 weeks, were used for RNA-sequencing analysis except the IFN-y sorted monocytes where four mice were used.
Venn diagram of Differentially Expressed Genes (DEGs) identified by pairwise comparisons of groups in an RNA-Seq analysis of
purified lung monocytes from uninfected (mock) and PR8-infected WT and IFN-γ-/- mice. C. Pathway enrichment networks
between DEG sets generated using the in-house package RichR. Commonly enriched pathways in two or more DEG sets are
considered nodes, while edges represent shared genes between pathways. The Cytoscape app MCODE was used to
systematically analyze the network for highly interconnected regions or clusters as described in the FAQ. The clusters are
presented as colored regions around groups of nodes in the network.

To better understand the specific genes that are differentially expressed between the three
groups of monocytes (mock vs WT-PR8, mock vs IFN--/--PR8, and WT-PR8 vs IFN--/--PR8) a
heatmap that quantified the log-fold change of individual inflammation-associated genes, or
genes involved in inflammatory pathways, were analyzed (figure 11). In WT-PR8 monocytes,
apoptosis-related genes (Tnf and Fasl) and pro-inflammatory signaling cascade proteins that
mediate cytokine production (Stats, Socs, Irf) were increased compared to mock mice (figure
11). The same expression patterns of pro-inflammatory genes in IFN--/--PR8 monocytes were
decreased relative to WT-PR8 mice further suggesting a shift from a pro-inflammatory, M1-like
state in WT-PR8 monocytes to an anti-inflammatory, M2-like state in IFN--/--PR8 monocytes.
This notion of a shift from M1 to M2 (pro-inflammatory to anti-inflammatory) monocytes is
further shown via network analysis and pathway mapping. An in-house R package, RichR, was
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used to generate pathway enrichment networks between comparisons. Commonly enriched
pathways in two or more comparisons were included as nodes, while edges represent shared
genes between pathways. Pathways related to immune signaling via cytokine production,
diapedesis, and T cell activation/differentiation pathways were enriched all suggesting a proinflammatory role in WT-PR8 monocytes.

Figure 11. Heatmap analysis of specific pro-inflammatory, anti-inflammatory, or signaling genes from WT-mock, WT-PR8, and
IFN--/--PR8 sorted monocytes seven days post-PR8 infection. DEGs in the heatmap have their relative directionality normalized
across rows to represent the change in expression levels across models.
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Cellular Source of IFN- During IAV Infection
Thus far, the role of IFN- on recruiting and activating inflammatory immune cells has
shown the mechanism by which the lungs are damaged during PR8 infection. However, the cells
that produce IFN- during PR8 infection are poorly understood. To test the hypothesis that
resident immune cells in the lungs produce IFN- early in infection to recruit damaging
inflammatory immune cells, intracellular cytokine staining of IFN- was performed in WT mice
seven days post infection. Single cell suspensions of aseptically removed lungs from WT-PR8
and mock-infected mice were performed and intracellular staining for flow cytometry was
immediately done. Once the cells had been stained for surface markers for NK cells (CD3NK1.1+), innate-like NK cells (CD11b+ NK1.1+), leukocytes (CD11b+), CD4+ T cells (CD3+
CD4+), and CD8+ T cells (CD3+ CD8+), the cells were permeabilized and stained for IFN- in the
cytoplasm of the cells. The cells were then fixed with formaldehyde to prevent the production
and subsequent release of IFN-, and the cells were analyzed via flow cytometry. While each cell
type expressed a small amount of IFN-, it was only marginally so when compared to their
respective mock controls. However, CD8+ T cells expressed over 14% of IFN-- when compared
to the mock control (figure 12). CD8+ T cells have been shown to play a role in early PR8
recognition in the lungs (figure 12) as well as direct viral-infected cells to undergo apoptosis.
These data suggest that CD8+ T cells are the major source of IFN- at day seven post-PR8
infection.
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Figure 12. Intracellular cytokine staining for IFN- in WT-PR8 mice seven days post PR8 infection as compared to mock-infected
mice (baseline). Cells analyzed were CD4+ T cells, CD8+ T cells, leukocytes, and NK cells. Data is representative of two
independent experiments using 6-8-week-old sex-matched mice. Six mice per group were used in each experiment. Data are
presented as ± SEM. ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05 using a one-way ANOVA with Tukey’s post-hoc test
for variance.

Role of the Adaptive Immune Response During IAV Infection
While CD8+ T cells produce IFN-, the role of the adaptive immune response in our
influenza mouse model, namely CD4 and CD8 T cells, has yet to be elucidated. Using the same
infection timeline as done previously, T cells in the lungs of PR8-infected mice were analyzed on
days 7, 14, 21, and 28 post-PR8 infection via flow cytometric analysis. The frequency of CD4+
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helper T cells (CD3+ CD4+) was marginally increased on day seven post-PR8 infection when
compared to the mock-infected mice (figure 12). The frequency of CD4+ T cells at days 14-28
post-PR8 infection were unchanged from mock-infected mice (figure 13). The lack of CD4+ T
cell expansion coupled with the limited production of IFN- by CD4+ T cells suggests a limited
inflammatory role during influenza virus infection. Conversely, cytotoxic CD8+ T cells were
drastically increased at day 7 post-PR8 infection when compared to mock-infected mice (40%
more CD8+ T cells, figure 13). Similar to helper T cells, the robust expansion of CD8+ T cells in
the lungs at day 7 post-PR8 infection was diminished and unchanged to mock-infected mice at
days 14-28 (figure 13). A larger frequency of T cells does not outright mean they are activated.
To test whether the observed increase in the frequency of T cells also resulted in an increase in
the activation of the same T cells, CD62L was measured on the surface via flow cytometry.
CD62L is an integrin and a marker for naïve T cells that have yet to be activated. The lack of
CD62L on T cells suggests they have been activated via their migration from secondary
lymphoid organs. It was observed that at day 7 post-PR8 infection, both CD4+ and CD8+ T cells
had a drastic reduction in CD62L expression when compared to the mock-infected controls
(figure 13). These data suggest that CD8+ T cells are the main type of effector T cell at day 7
post-PR8 infection in terms of total frequency and activation. CD4+ T cells, while activated, do
not increase in frequency relative to mock-infected controls. Coupled with the lack of IFN-
production, these data also suggest a minimal role for CD4+ T cells in the pathogenic state of the
lungs during influenza virus infection and rather, cytotoxic CD8+ T cells being the culprit.

94

Figure 13. Adaptive immune response analysis of CD4+ and CD8+ T cells on days 7, 14, 21, and 28 post-PR8 infection. CD62L
expression of the surface of T cells was measured on day 7 to assess the activaiton states of the T cells. Data is representative of
two independent experiments using 6-8-week-old sex-matched mice. Five to six mice per group were used in each experiment.
Data are presented as ± SEM. ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05 using a one-way ANOVA with Tukey’s
post-hoc test for variance.

Summary
This chapter began with a brief overview detailing the procedures for analyzing the data,
the reliability of the instrumentation used for each experiment, and the infection model used to
test the central hypothesis. The focus of this study sought to test how the host’s immune response
is responsible for the respiratory epithelium damage observed in acute influenza A virus
infection. Descriptive statistics were used to ensure rigor and account for variance between the
groups.
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The data suggested that IMs are recruited to the lungs early in infection and their
presence results in cell damage, cell death, and increased morbidity amongst mice infected with
PR8. Their absence resulted in less morbidity in mice. Further, the antiviral, pro-inflammatory
cytokine, IFN-, is a key regulator of CCL2 production, and thus, CCR2+ IM recruitment into the
lungs. IFN--deficient mice resembled the lower morbidity observed in CCR2 knock-out mice in
terms of weight loss, pro-inflammatory cytokine burden, and inflammatory cell recruitment.
Finally, the data suggested that CD8+ cytotoxic T cells are the main immune cell that produces
IFN- and in the absence of an adaptive immune response, the inflammatory burden decreases.
The results from this experiment will provide key insights into the cross-talk between the
immune response and epithelial cells during acute influenza A virus infection. The resulting
increase in cell death correlate with an increase in morbidity. The increase in cell death is
mediated by a key leukocyte that is activated by CD8+ T cells via the production of IFN-.
Further, cutting edge RNA sequencing of inflammatory monocytes provides a window into the
transcriptome of these cells as they mediate much of the lung damage witnessed during acute
respiratory infection. Therapeutic intervention to alleviate the damage to the respiratory
epithelium by eliminating or decreasing the frequency of IMs in the lungs of IAV-infected
individuals may reduce the observed morbidity and mortality associated with acute viral
infections.
Currently, there is a paper in revision that details the data above. Many of the future
considerations stem from the results of that paper and as such, there are several intriguing
hypotheses that will be followed up.
Chapter 5 will provide an interpretation of the data as well as conclusions that can be
drawn from this experiment. Further, the discussion in chapter 5 will expand the current
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knowledge that was detailed in the literature review section. Considerations for future studies as
well as limitations to this study will also be discussed.
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Chapter 5: Summary, recommendations, implications, and conclusions

This research was conducted in order to further understand the mechanisms by which
influenza A virus elicits an over-zealous, hyper-immune response in the host. The immune
response limits viral propagation through the secretion of pro-inflammatory cytokines as well as
direct cell-to-cell interactions which further limit the spread of the virus at the expense of the
host’s health. Understanding one of the key mechanisms by which inflammatory monocytes are
recruited to the lungs during acute viral infection as well as the protein mediators in eliciting
their damaging response are crucial to limiting the morbidity of influenza viruses.
Insights into the mechanisms of lung damage caused by the host’s immune response may
provide critical points for therapeutic intervention and reduce the observed morbidity and
mortality the world experiences every year due to influenza virus infections. The link between
the adaptive immune response and the innate immune response, as they relate to damage to the
host’s respiratory epithelium, is a novel mechanism in which influenza viruses inadvertently
cause death.
This chapter will present a brief summary of the purpose of these experiments,
summarize the procedures that were used in order to test the central hypothesis, and summarize
the relevant findings. This chapter will conclude with limitations of the study as well as
recommendations for future studies. The implications this study may have on the field of
influenza virus research going forward will be addressed as it pertains to the broader literature.
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Summary of purpose
The CDC estimates there are approximately 65,000 deaths every year due to influenza
virus infections or complications related to influenza virus. (11, 12) Many of the global
pandemics that have occurred over the previous century have been caused by influenza virus.
(11, 12) Further, seasonal influenza vaccines exist but their efficacy can be limited and
compliance with vaccinations are often low, ranging from 50 to 60 percent. (11) Antiviral
therapies for influenza virus are often used for individuals infected with the virus but proactive
treatment against viruses is often the best course of action. (12)
The deaths caused by influenza virus are the result of acute respiratory distress syndrome
(ARDS) or secondary bacterial infections due to the damage elicited by the virus. (14-16) The
mechanisms by which the virus makes the lungs permissive to bacterial infections in unknown
and the evidence is scarce. Therefore, the purpose of this study was to elucidate the mechanisms
by which influenza virus infection damaged the respiratory epithelium due to the host’s immune
response. ARDS is the result of a cytokine storm which then increases the vascular permeability
of the lungs and fluid begins to leak in. (14) Once this occur, the individual’s blood pressure
drops, and this can result in death. (14, 15) Understanding how the cytokine storm is produced,
and the cells responsible for mediating the lung damage, are two questions that the field has yet
to answer.
This study showed that there is a large influx of CD11b+ Ly6C+ CCR2+ leukocytes,
namely inflammatory monocytes, that are recruited by the infected epithelial cells to the lungs in
order to limit the spread of the virus. However, the inflammatory monocytes directly induce
apoptosis or necroptosis in infected epithelial cells through the TNF receptor apoptosis inducing
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ligand (TRAIL) of their cell surface. The direct cell damage increases the morbidity in the
infected individual.
While inflammatory monocytes are the key mediators of cell damage in the lungs, the
antiviral protein, IFN-, induces a pro-inflammatory state and is responsible for much of the
recruitment and activation of inflammatory monocytes. The majority of IFN- is produced by
lung-resident CD8+ T cells early in infection and without IFN- or CD8+ T cells, the observed
morbidity caused by influenza virus infection can be limited.

Summary of procedures
For this study, the researcher used a mouse model in order to recapitulate an influenza
virus infection in an ethical and expedited way. Using the C57BL/6 mouse (WT), mice were
infected with a sub-lethal dose of H1N1 influenza A virus A/PR8/1934 (PR8) and monitored for
seven days. Body weight loss was used as a measure of morbidity and, when left alone, 100% of
mice recovered even after losing up to 20% of their starting body weight. The B6 mouse
background was used in this study because these mice are less sensitive to pain compared to
other animal models and they are easy to breed. The BALB/c mouse strain tends to skew towards
an anti-inflammatory Th2 response while the B6 background does not further making it a better
model for viral studies.
Protein-specific knockout mice were used to assess their role when compared to proteincompetent controls. These knockout mice included CCR2-/- and IFN--/- which allowed for the
assessment of inflammatory monocyte recruitment, the role of the type II interferon response,
and the role of the adaptive immune response respectively.
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Flow cytometric analysis was employed to study cell populations in the lungs of PR8infected and mock-infected mice as well as determine the concentration of inflammatory
cytokines and inflammatory chemokines.
In order to determine statistical significance and account for variability between groups, a
t-test with an alpha level of 0.05 was used for comparisons between WT-PR8 and mock-infected
groups. For comparisons between more than two groups, a One-Way ANOVA was used with an
adjusted alpha level of 0.05. A Tukey’s post-hoc test was used after the One-Way ANOVA
analysis to determine where the differences between groups was, if there was any difference at
all.

Research questions
The first research question sought to determine the inflammatory phenotype of WT-PR8
mice before, during, and after acute influenza virus infection. To confirm the model was
applicable to influenzas virus research, the weight loss, cytokines, chemokines, and lung damage
were evaluated in WT mice infected with PR8. There was a statistically significant difference in
weight loss compared to mock-infected mice and pro-inflammatory cytokine and proinflammatory chemokine production were elevated. Histological analysis showed severe loss of
large airway structures and a large volume of immune cell recruitment into the airways all
indicative of acute respiratory infection.
Flow cytometric analysis of single cells from the lungs of infected mice showed a large
frequency of inflammatory monocytes relative to the mock-infected controls. The phenotype of
the inflammatory monocytes was further indicative of their cell-damaging, pro-inflammatory
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nature as macrophage activation markers and integrins were all upregulated in CCR2 +
inflammatory monocytes.
The second research question tested whether CCR2+ inflammatory monocytes cause lung
pathology during influenza virus infection. By using a CCR2-/- mouse model infected with the
same plaque forming units (PFU) of PR8 as the WT mice, the morbidity associated with CCR2proficient immune cells could be analyzed. Weight loss, inflammatory cytokines, inflammatory
chemokines, and lung pathology were less severe in the CCR2-/--PR8 mice compared to the WTPR8 mice suggesting inflammatory monocytes play a damaging role during influenza virus
infection.
As controls, flow cytometry was used to analyze CCR2+ cells in mock-infected, WTPR8, and CCR2-/--PR8 mice. The frequency of CCR2+ inflammatory monocytes in WT-PR8
mice was similar to what was observed in the experiments covering the first research question
while there was only background from the CCR2-/--PR8 mice. The concentration of CCL2 in
CCR2-/--PR8 mice was elevated when compared to WT-PR8 mice also suggesting the knock-out
mouse model was truly deficient of CCR2+ expression. This is due to free CCL2 not being bound
by its receptor and thus, not being internalized and removed from the periphery.
Research question three examined the role of the type II interferon response in the PR8
mouse model. In research question one, it was apparent that the antiviral protein, IFN-, was the
most abundant pro-inflammatory cytokine measured. To assess the role of IFN-, an IFN--/mouse was used. For these experiments, 250 PFU of PR8 was used to infect IFN--/--PR8 mice.
When IFN- was absent, the concentration of CCL2 was decreased in addition to canonical proinflammatory cytokines, TNF- and IFN- while the anti-inflammatory cytokine, IL-10, was
increased. IFN--/--PR8 mice loss less body weight when compared to WT-PR8 mice but there
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was still significant morbidity as they lost 10% of their starting weight compared to mockinfected controls.
The decrease in CCL2 suggested that IFN--/- may play a role in recruiting CCR2+
inflammatory monocytes to the lungs. Flow cytometry experiments revealed a decrease in the
frequency of inflammatory monocytes compared to WT-PR8 mice. This reduction in
inflammatory monocytes in IFN--/--PR8 mice corresponded with less severe immunopathology
in the lungs as indicated by less large airway damage via histological staining.
The fourth research question involved sorting monocytes from mock WT mice, WT-PR8
mice, and IFN--/--PR8 mice and subsequently extracting RNA for RNA sequencing analysis.
Full transcriptome comparisons between groups revealed several hundred differentially
expressed genes (DEGs) that comprised the severity of the pro-inflammatory response in
monocytes. Interestingly, the largest variance in DEGs was between the mock control monocytes
and the IFN--/--PR8 monocytes (figure 9, 1241 genes). To better understand the role of the
DEGs, pathway analysis was performed. It was determined that CCR5 signaling in macrophages,
chemokine signaling, complement fixing, cytotoxic T lymphocyte-mediating apoptosis,
inflammasome pathways, leukocyte extravasion, the NF-kB pathway, and iNOS and ROS
production in macrophages were also significantly decreased in the IFN--/--PR8 monocytes
when compared to WT-PR8 mice. These data suggest that the discrepancy in DEGs of IFN--/-PR8 monocytes is most likely due to the downregulation of pro-inflammatory genes that are
regulated by IFN-. Further, the lack of pro-inflammatory gene induction in IFN--/--PR8
monocytes suggests a more anti-inflammatory, or M2 macrophage-like state. To test the
hypothesis of pro-inflammatory genes being negatively regulated in IFN--/--PR8 monocytes, the
log-fold change in gene expression between all three groups of monocytes was analyzed via
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heatmap analysis. Pro-inflammatory, pro-apoptotic-inducing genes were increased in WT-PR8
monocytes compared to IFN--/--PR8 monocytes. Further, pro-inflammatory signaling genes, like
Stats, MAP kinase, and interferon regulatory factors (Irf), were all decreased in IFN--/--PR8
monocytes compared to WT-PR8 mice further suggesting an M2 state without the presence of
IFN-.
The fifth research question assessed which immune cells are the major source of IFN-
production in the lungs during influenza A virus infection. Research question one detailed the
robust increase in IFN- concentration in the lungs during influenza A virus infection compared
to mock-infected controls. Research question three elaborated tested the hypothesis that IFN-,
while an anti-virial mediator, also contributed to the recruitment of CCR2+ IMs in the lungs. To
better understand which cells are coordinating this non-CCL2-mediated recruitment of IMs, the
immune cell that produces IFN- was tested via intracellular protein staining.
A wide array of immune cells were analyzed for IFN- production. NK cells and NKT
cells have been thought to produce IFN-. However, the robust expansion of CD8+ T cells in our
model suggested these cytotoxic T cells may be the main producer of IFN-. NK and NKT cells
were found to produce a very small amount of IFN- in the influenza-infected mice compared to
mock-infected mice. Similarly, CD11b+ leukocytes barely produced IFN- above baseline levels
compared to mock controls. When assessing IFN- production in T cells, CD4+ T cells produced
6% more IFN- compared to mock controls but overwhelmingly, CD8+ T cells produced the bulk
of IFN- in the lungs of influenza-infected mice. More than 14% of CD8+ T cells produced IFN-
at day 7 post-influenza virus infection suggesting these cytotoxic T cells are responsible for the
interactions between epithelial cell damage and immune cell-mediated death.
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The sixth research question described the expansion of the adaptive immune response in
the lungs of influenza virus-infected mice. Because CD8+ T cells were found to produce the
majority of IFN-, the expansion of T cells in the lungs was analyzed.
The frequency of CD4+ T cells was slightly increased seven days post-influenza virus
infection when compared to mock-infected mice. The frequency of CD4+ T cells was unchanged
from mock-infected mice on days 14 and 21 post-influenza virus infection suggesting a minimal
role during acute viral infection. Conversely, there was a pronounced expansion of CD8+ T cells
at day 7 post-influenza virus infection. This expansion remained elevated when compared to
mock-infected controls at 21 days post-infection suggesting the CD8+ T cell response is the
predominant T cells response during influenza virus infection.
Further, both cytotoxic and helper T cell populations were activated seven days post
infection relative to mock-infected controls as assessed by CD62L expression on the surface of
the cells. These data suggest that not only is there an increase in the frequency of both types of T
cells at day seven post-infection, but the infiltrating cells have been activated.

Limitations of the study
IFN- is an incredibly potent anti-viral cytokine that mediates the functions of
monocytes, macrophages, B cells, and NK cells. Further, IFN- plays a role in priming the
immune response, namely macrophages in the lungs, against bacterial infections caused by acute
lung damage. The outcome of viral clearance and the subsequent lack of macrophage priming
during viral infection without IFN- is unknown. The present study does not address viral
clearance over time in IFN--/- mice nor does it address subsequent influenza virus infections as
is often witnessed seasonally. While this study does provide evidence to suggest the lack of IFN-
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 decreases the recruitment of inflammatory monocytes while concurrently reducing damage to
the respiratory epithelium, the consequences of reduced viral clearance and reduced priming of
important immune cells in bacterial infections is unknown.
RNA sequencing of sorted monocytes from WT-mock controls, WT-PR8, and IFN--/-PR8 was performed in research question four. The data from RNA sequencing suggested
differential inflammatory states of inflammatory monocytes from PR8-ifnected mice via
transcriptome changes. However, transcriptome changes do not mean changes on the protein
level. To determine if the observed changes in inflammatory genes translate to changes in protein
synthesis and subsequent cellular interactions, in vitro studies that measure apoptosis of
epithelial cells via sorted monocytes need to be performed. Increases in surface proteins like
TRAIL and FasL on IMs and increases in sphingomyelin on the surface of epithelial cells as
measured by Annexin V using WT-PR8 monocytes would be a good example of confirming the
RNA sequencing data. Sorted IFN--/--PR8 should have a decrease in surface expression of proapoptotic ligands and less death in epithelial cells would be observed to confirm the RNA
sequencing data. However, the observed trends in the RNA sequencing data are highly indicative
of changes in the phenotypes of monocytes from WT-PR8 and IFN--/--PR8 mice. The RNA
sequencing data confirms the observed flow cytometry, histology, and weight change data in
research questions one, two, and three.
This study did not delineate which subsets of helper T cells were present in the lungs of
PR8 infected B6 mice. Specifically, there was a minimal, but significant increase in the
frequency of CD4+ T cells in the lungs of mice infected with PR8 seven days post-infection.
These T cells could be Th1, Th2, Th17, Th9, regulatory T cells (Tregs), or follicular helper T
cells. The phenotype of T cells is suggestive of the type of inflammatory response where Th1,
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Th17, and Th9 are indicative of a pro-inflammatory response while Th2 and Tregs are antiinflammatory. While the frequency and expansion of CD8+ T cells was much higher, the
contribution to the overall immune response, even in a small way, is necessitated by the helper T
cell response.

Recommendations for further study
The following recommendation for further research were derived from the finding of this
research study: (a) this study did not test the specific interactions between inflammatory
monocytes and IFN-. To test this relationship, deletion of the IFN- receptor (IFNRa) on
inflammatory monocytes would deduce the mechanism and role IFN- has on these cells in the
bone marrow and lungs. In addition to the role of IFNRa on monocytes, deletion or truncating
the IFN- gene in only CD8+ T cells, thereby creating an IFN- knock out in only CD8+ T cells
would further address the relationship between two subsets of death-mediating immune cells. (b)
The role of the adaptive immune response during influenza virus infection should be further
studied through the analysis of adoptive transfer experiments between mice. Specifically, CD8+
T cells from PR8-infected mice should be intraocularly transferred into WT mice, IFN--/- mice,
and CCR2-/- mice that are either uninfected or infected with PR8 to assess the lung damage
caused by PR8-activated CD8+ T cells. These studies will address the role of activated CD8+ T
cells and the cell death mediated by IFN- produced by CD8+ T cells as well as their recruitment
of IMs. (c) IFN- is a major activator of B cells during infection and as such, assessing the role
of the humoral immune response during influenza virus infection is extremely important.
Antibody-mediated protection from subsequent influenza virus infections is thought to be a main
target of influenza-based vaccines. As such, understanding the role of IFN- in B cell activation
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during influenza virus infection would provide evidence for the necessity of antibody-based
therapies. (d) One of the leading causes of death during the 1918 Influenza Pandemic was not
specifically the virus but rather, secondary bacterial infections that led to pneumonia and
bacterial sepsis. Today, bacterial infections result in similar morbidities in influenza-infected
patients ever year. Future studies using the influenza model that was used in these studies to
determine the role of IMs and IFN- in secondary bacterial infections may provide insight on the
immune response’s role in allowing commensal bacteria to invade, adhere to the respiratory
epithelium, and colonize thereby increasing the disease state of those infected. The ways in
which IMs damage the respiratory epithelium, and ablating much of that damage, may decrease
the incidence and/or severity of secondary bacterial infections after the primary influenza virus
infection. (e) Immunodeficiencies and influenza virus are also major health concerns. Individuals
with selective immunoglobulin A deficiency have B cells that produce every antibody normally
with the sole exception of IgA. IgA transiently protects mucosal surfaces and individuals that are
deficient in IgA have a higher incidence of secondary bacterial pneumonia caused by acute
respiratory viral infections. Thus, the role of IFN-, B cell activation, and the role of IgA during
influenza infection as a means of protecting the mucosal respiratory epithelium warrants future
study. (f) the current SARS-CoV-2 pandemic has raised many questions regarding the role of
acute respiratory viral infections. SARS has been shown to evade the immune response by
limiting the induction of the type I interferon response. Decreases in the type I interferon
response have correlated with increases in IL-6 which was observed in the IFN--/- mouse model
(data not shown). Therefore, studies into each branch of the interferon response may provide
insight into mechanisms by which influenza A virus evades the immune response, rapidly
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advances the viral infection, and subsequently requires inflammatory monocytes via IFN-
activation for viral clearance.

Conclusions
Influenza virus caused the worst pandemic in human history during the 1918-1919
pandemic. The loss of human lives, economic cost, and emotional toll the virus caused the world
is still felt in the DNA of people today. The importance of understanding the virological,
immunological, and molecular mechanisms involved in influenza pathogenesis cannot be
understated. Further, as other acute respiratory viruses continue to cause pandemics and the loss
of human life increases, a greater understanding of respiratory viruses in general will assist with
navigating the coming pandemics.
In the data presented here, the interactions between the host’s immune response and
influenza virus were assessed through a variety of cutting-edge techniques that have helped grow
our understanding of host-pathogen interactions. Monocytes, a precursor to resident
macrophages, are recruited by the chemokine, CCL2, to the site of infection via the CCR2
receptor. Once there, these monocytes begin to aid in the defense against the virus by directly
interacting with virally-infected epithelial cells. Now termed inflammatory monocytes for their
ability to kill epithelial cells and respond to pro-inflammatory cytokines, inflammatory
monocytes become further activated by the anti-viral protein, IFN-. Inflammatory monocytes
then cause damage to the respiratory epithelium that increases the pulmonary vasculature. Here,
much of the pathology associated with influenza virus occurs as acute respiratory distress
syndrome (ARDS) may manifest and cause significant morbidity to the host.
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This study provides a novel conceptual framework by which the host’s immune response,
when left over-activated, may cause more damage to the host than the initial viral infection. By
understanding the molecular mechanisms that drive tissue damage via inflammatory monocytes
through their recruitment to the lungs, their activation and functions at the site of infection, and
the immune system’s ability to limit an inflammatory state, the morbidity and mortality
associated with influenza virus can be limited. Novel therapeutics against the host’s own
response might be the best choice we have to limit deaths cause by influenza virus. Further,
vaccine development can be furthered by understanding the ways the host responds to influenza
virus and potentially avoid the next influenza pandemic altogether.
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